Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

Articles published in
Circulation
    July 2021
  1. JOYNT MADDOX KE, Gilstrap LG
    Is Rising Cardiovascular Spending a Good News or Bad News Story?
    Circulation. 2021;144:283-285.
    >> Share

  2. PIRILLO A, Catapano AL
    Omega-3 for Cardiovascular Diseases: Where Do We Stand After REDUCE-IT and STRENGTH?
    Circulation. 2021;144:183-185.
    >> Share

  3. CHAITMAN BR, Reynolds HR, Maron DJ, Hochman JS, et al
    Response by Chaitman et al to Letter Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
    Circulation. 2021;144:e14-e15.
    >> Share

  4. CORREIA LCL, Viana MS
    Letter by Correia and Viana Regarding Article, "Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons".
    Circulation. 2021;144:e12-e13.
    >> Share


  5. Retraction and Replacement of: Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Circulation. 2021;144:e36.
    >> Share

  6. MEHTA SR
    Achieving Complete Revascularization for Multivessel Coronary Artery Disease.
    Circulation. 2021;144:110-112.
    >> Share

  7. PATEL AP, Wang M, Kartoun U, Ng K, et al
    Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study.
    Circulation. 2021 Jul 12. doi: 10.1161/CIRCULATIONAHA.120.052430.
    >> Share

  8. STREED CG JR, Beach LB, Caceres BA, Dowshen NL, et al
    Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jul 8:CIR0000000000001003. doi: 10.1161/CIR.0000000000001003.
    >> Share

  9. ZHANG Q, Burrage MK, Lukaschuk E, Shanmuganathan M, et al
    Towards Replacing Late Gadolinium Enhancement with Artificial Intelligence Virtual Native Enhancement for Gadolinium-Free Cardiovascular Magnetic Resonance Tissue Characterization in Hypertrophic Cardiomyopathy.
    Circulation. 2021 Jul 7. doi: 10.1161/CIRCULATIONAHA.121.054432.
    >> Share

  10. LI Y, Lu G
    Letter by Li and Lu Regarding Article, "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry".
    Circulation. 2021;144:e6-e7.
    >> Share

  11. HENDREN NS, de Lemos JA, Grodin JL
    Response by Hendren et al to Letter Regarding Article, "Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry".
    Circulation. 2021;144:e8-e9.
    >> Share

  12. NELSON AJ, Pagidipati NJ, Aroda VR, Cavender MA, et al
    Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
    Circulation. 2021;144:74-84.
    >> Share

  13. SCHUNK SJ, Triem S, Schmit D, Zewinger S, et al
    Interleukin-1alpha (IL-1alpha) is a Central Regulator of Leukocyte-Endothelial Adhesion in Myocardial Infarction and in Chronic Kidney Disease.
    Circulation. 2021 Jul 1. doi: 10.1161/CIRCULATIONAHA.121.053547.
    >> Share

    June 2021
  14. WERESKI R, Kimenai DM, Taggart C, Doudesis D, et al
    Cardiac Troponin Thresholds and Kinetics to Differentiate Myocardial Injury and Myocardial Infarction.
    Circulation. 2021 Jun 25. doi: 10.1161/CIRCULATIONAHA.121.054302.
    >> Share


  15. Correction to: A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT).
    Circulation. 2021;143:e1118.
    >> Share


  16. Correction to: Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
    Circulation. 2021;143:e1116.
    >> Share

  17. DROBNI ZD, Mayrhofer T, Hoffmann U, Neilan TG, et al
    Response to Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1033-e1034.
    >> Share

  18. SARAYANI A, Jugl S, Winterstein AG
    Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".
    Circulation. 2021;143:e1031-e1032.
    >> Share

  19. REILLY MP, Bornfeldt KE
    Integrative Multiomics Approaches for Discovery of New Drug Targets for Cardiovascular Disease.
    Circulation. 2021;143:2471-2474.
    >> Share

  20. YEGHIAZARIANS Y, Jneid H, Tietjens JR, Redline S, et al
    Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 21:CIR0000000000000988. doi: 10.1161/CIR.0000000000000988.
    >> Share

  21. DAMLUJI AA, van Diepen S, Katz JN, Menon V, et al
    Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Jun 15:CIR0000000000000985. doi: 10.1161/CIR.0000000000000985.
    >> Share

  22. ALBERT MA, Carnethon MR, Watson KE
    Disparities in Cardiovascular Medicine.
    Circulation. 2021;143:2319-2320.
    >> Share

  23. LEE H, Yano Y, Cho SMJ, Lee HH, et al
    Associations of Ideal Cardiovascular Health and Its Change During Young Adulthood With Premature Cardiovascular Events: A Nationwide Cohort Study.
    Circulation. 2021 Jun 14. doi: 10.1161/CIRCULATIONAHA.121.054212.
    >> Share

  24. REYNOLDS HR, Picard MH, Spertus JA, Peteiro J, et al
    Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study.
    Circulation. 2021 Jun 1. doi: 10.1161/CIRCULATIONAHA.120.046791.
    >> Share

    May 2021
  25. ALTHOUSE AD, Below JE, Claggett BL, Cox NJ, et al
    Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association.
    Circulation. 2021 May 25:CIRCULATIONAHA121055393.
    >> Share

  26. KARIO K, Kanegae H, Hoshide S
    Response by Kario et al to Letter Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e982-e983.
    >> Share

  27. CHANG AY, Barry M, Harrington RA
    The Need to Expand the Framework of Environmental Determinants of Cardiovascular Health From Climate Change to Planetary Health: Trial by Wildfire.
    Circulation. 2021;143:2029-2031.
    >> Share

  28. PENGO MF, Bisogni V, Martinez-Garcia MA
    Letter by Pengo et al Regarding Article, "Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study".
    Circulation. 2021;143:e980-e981.
    >> Share

  29. GAO R, Wang L, Bei Y, Wu X, et al
    LncRNA CPhar Induces Cardiac Physiological Hypertrophy and Promotes Functional Recovery After Myocardial Ischemia-Reperfusion Injury.
    Circulation. 2021 May 21. doi: 10.1161/CIRCULATIONAHA.120.050446.
    >> Share

  30. TAKAHASHI K, Serruys PW, Gao C, Ono M, et al
    Ten-Year All-Cause Death According to Completeness of Revascularization in Patients with Three-Vessel Disease or Left Main Coronary Artery Disease: Insights from the SYNTAX Extended Survival Study.
    Circulation. 2021 May 20. doi: 10.1161/CIRCULATIONAHA.120.046289.
    >> Share

  31. LOPES RD, Alexander KP, Hochman JS, Maron DJ, et al
    Response by Lopes et al to Letter Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e961-e962.
    >> Share

  32. MORGAN H, Clayton T, Perera D
    Letter by Morgan et al Regarding Article, "Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease Patients With a History of Heart Failure or Left Ventricular Dysfunction: Insights From the ISCHEMIA Trial".
    Circulation. 2021;143:e959-e960.
    >> Share

  33. ROHATGI A
    Stressing the Endothelium to Assess Localized Inflammatory Potential and the Risk for Atherosclerotic Cardiovascular Disease.
    Circulation. 2021;143:1946-1948.
    >> Share

  34. KUWABARA M, Mori M, Komoto S
    Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease.
    Circulation. 2021;143:1929-1931.
    >> Share

  35. DOCHERTY KF, Campbell RT, Brooksbank KJM, Dreisbach JG, et al
    The Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients with Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
    Circulation. 2021 May 13. doi: 10.1161/CIRCULATIONAHA.121.054892.
    >> Share

  36. HENDRICKSON BS, Stephens RE, Chang JV, Amburn JM, et al
    Cardiovascular Evaluation After COVID-19 in 137 Collegiate Athletes: Results of an Algorithm-Guided Screening.
    Circulation. 2021;143:1926-1928.
    >> Share

  37. HAKALA JO, Pahkala K, Juonala M, Salo P, et al
    Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study.
    Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052358.
    >> Share

  38. ZHAO M, Nakada Y, Wei Y, Bian W, et al
    Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
    Circulation. 2021 May 6. doi: 10.1161/CIRCULATIONAHA.120.049497.
    >> Share

    April 2021
  39. BIRGER M, Kaldjian AS, Roth GA, Moran AE, et al
    Spending on Cardiovascular Disease and Cardiovascular Risk Factors in the United States: 1996 - 2016.
    Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.053216.
    >> Share

  40. SARTO P, Zorzi A, Merlo L, Vessella T, et al
    Serial Versus Single Cardiovascular Screening of Adolescent Athletes.
    Circulation. 2021;143:1729-1731.
    >> Share

  41. POWELL-WILEY TM, Poirier P, Burke LE, Despres JP, et al
    Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Apr 22:CIR0000000000000973. doi: 10.1161/CIR.0000000000000973.
    >> Share

  42. FIGTREE GA, Broadfoot K, Casadei B, Califf R, et al
    A Call to Action for New Global Approaches to Cardiovascular Disease Drug Solutions.
    Circulation. 2021 Apr 20:CIR0000000000000981. doi: 10.1161/CIR.0000000000000981.
    >> Share

  43. KUEHN BM
    Novel Approaches Expand Access to Cardiovascular Preventive Care.
    Circulation. 2021;143:1629-1630.
    >> Share

  44. NEAL B, Wu J
    Sodium, Blood Pressure, and the Likely Massive Avoidable Burden of Cardiovascular Disease.
    Circulation. 2021;143:1568-1570.
    >> Share

  45. SCHAUER PR, Nissen SE
    After 70 Years, Metabolic Surgery Has Earned a Cardiovascular Outcome Trial.
    Circulation. 2021;143:1481-1483.
    >> Share

  46. JIA C, Anderson JLC, Gruppen EG, Lei Y, et al
    High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
    Circulation. 2021 Apr 12. doi: 10.1161/CIRCULATIONAHA.120.050808.
    >> Share

  47. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent with the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial.
    Circulation. 2021 Apr 7. doi: 10.1161/CIRCULATIONAHA.120.052766.
    >> Share

  48. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
    Response by Bangalore et al to Letter Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e809-e810.
    >> Share

  49. FERRARO R, Arbab-Zadeh A
    Letter by Ferraro and Arbab-Zadeh Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e805-e806.
    >> Share

  50. SHAH R
    Letter by Shah Regarding Article, "Routine Revascularization Versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials".
    Circulation. 2021;143:e807-e808.
    >> Share

  51. WENGER NK, Lewis SJ
    Incremental Change versus Disruptive Transformation: COVID-19 and the Cardiovascular Community.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.121.053860.
    >> Share

  52. LANSKY AJ, Kereiakes DJ, Baumbach A, Windecker S, et al
    Novel Supreme(TM) DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation after DES implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.052482.
    >> Share

  53. YACOUB M, Labib D
    Toward Meeting the Challenges of Improving Cardiovascular Health in Egypt.
    Circulation. 2021;143:1341-1342.
    >> Share

  54. SAHOO S, Adamiak M, Mathiyalagan P, Kenneweg F, et al
    Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases: Roadmap to the Clinic.
    Circulation. 2021;143:1426-1449.
    >> Share

  55. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
    Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
    Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.
    >> Share

    March 2021
  56. GARGIULO G, Nagler M, Valgimigli M
    Response by Gargiulo et al to Letter Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
    Circulation. 2021;143:e797-e798.
    >> Share

  57. ANGIOLILLO DJ, Bhatt DL, Stone GW
    Letter by Angiolillo et al Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial".
    Circulation. 2021;143:e795-e796.
    >> Share

  58. PARIKH NI, Gonzalez JM, Anderson CAM, Judd SE, et al
    Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Mar 29:CIR0000000000000961. doi: 10.1161/CIR.0000000000000961.
    >> Share

  59. ANAND A, Lee KK, Chapman AR, Ferry AV, et al
    High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial.
    Circulation. 2021 Mar 23. doi: 10.1161/CIRCULATIONAHA.120.052380.
    >> Share


  60. Correction to: Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2021;143:e792-e793.
    >> Share

  61. DEFILIPPI CR, Mills NL
    Rapid Cardiac Troponin Release After Transient Ischemia: Implications for the Diagnosis of Myocardial Infarction.
    Circulation. 2021;143:1105-1108.
    >> Share

  62. JANKOWSKI J, Floege J, Fliser D, Bohm M, et al
    Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
    Circulation. 2021;143:1157-1172.
    >> Share

  63. GREEN JB
    Cardiovascular Consequences of Gestational Diabetes.
    Circulation. 2021;143:988-990.
    >> Share

  64. PELLEGRINI D, Kawakami R, Guagliumi G, Sakamoto A, et al
    Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study.
    Circulation. 2021;143:1031-1042.
    >> Share

  65. BOLLI A, Di Domenico P, Pastorino R, Busby GB, et al
    Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background.
    Circulation. 2021 Mar 8. doi: 10.1161/CIRCULATIONAHA.120.051843.
    >> Share

  66. HENRY TD, Tomey MI, Tamis-Holland JE, Thiele H, et al
    Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.
    Circulation. 2021 Mar 4:CIR0000000000000959. doi: 10.1161/CIR.0000000000000959.
    >> Share

  67. PENG AW, Dardari ZA, Blumenthal RS, Dzaye O, et al
    Very High Coronary Artery Calcium (CAC >/= 1000) and Association with CVD Events, Non-CVD Outcomes, and Mortality: Results from The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2021 Mar 2. doi: 10.1161/CIRCULATIONAHA.120.050545.
    >> Share

    February 2021
  68. PUTOT A, Cottin Y, Zeller M
    Letter by Putot et al Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
    Circulation. 2021;143:e250-e251.
    >> Share

  69. HORIUCHI Y, Wettersten N, Maisel A
    Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction".
    Circulation. 2021;143:e252-e253.
    >> Share


  70. Correction to: Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy.
    Circulation. 2021;143:e744.
    >> Share

  71. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    >> Share

  72. YONG CM, Balasubramanian S, Douglas PS, Agarwal P, et al
    Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences.
    Circulation. 2021;143:755-757.
    >> Share

  73. ELHARRAM M, Hillier E, Hawkins S, Mikami Y, et al
    Regional Heterogeneity in the Coronary Vascular Response in Women With Chest Pain and Nonobstructive Coronary Artery Disease.
    Circulation. 2021;143:764-766.
    >> Share

  74. JI H, Niiranen TJ, Rader F, Henglin M, et al
    Sex Differences in Blood Pressure Associations With Cardiovascular Outcomes.
    Circulation. 2021;143:761-763.
    >> Share

  75. FERRACANE E, Bartoli L, Messori A
    Letter by Ferracane et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e232-e233.
    >> Share

  76. KESSLER T, Cassese S, Kastrati A
    Letter by Kessler et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e230-e231.
    >> Share

  77. NAVARESE EP, Khan SU, James S
    Response by Navarese et al to Letters Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e236-e237.
    >> Share

  78. ANGIOLILLO DJ, Bhatt DL, Cannon CP, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
    Circulation. 2021;143:583-596.
    >> Share

  79. ALKHALIL M, Kuzemczak M
    Letter by Alkhalil and Kuzemczak Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".
    Circulation. 2021;143:e234-e235.
    >> Share

  80. YBARRA LF, Rinfret S, Brilakis ES, Karmpaliotis D, et al
    Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.
    Circulation. 2021;143:479-500.
    >> Share

  81. GUNDERSON EP, Sun B, Catov JM, Carnethon M, et al
    Gestational Diabetes History and Glucose Tolerance After Pregnancy Associated With Coronary Artery Calcium in Women During Midlife: The CARDIA Study.
    Circulation. 2021 Feb 1. doi: 10.1161/CIRCULATIONAHA.120.047320.
    >> Share

    January 2021
  82. BRAUER M, Casadei B, Harrington RA, Kovacs R, et al
    Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology.
    Circulation. 2021 Jan 28:CIRCULATIONAHA120052666.
    >> Share

  83. TOMCSANYI J, Paulik R, Fresz T
    Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
    Circulation. 2021;143:397-400.
    >> Share

  84. OLLITRAULT P, Dolladille C, Chretien B, Milliez P, et al
    Cardiovascular Toxicities Associated With Loperamide: Analysis of the World Health Organization Pharmacovigilance Database.
    Circulation. 2021;143:403-405.
    >> Share

  85. SNIDER JC, Riley LA, Mallory NT, Bersi MR, et al
    Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling after Myocardial Infarction.
    Circulation. 2021 Jan 21. doi: 10.1161/CIRCULATIONAHA.120.051517.
    >> Share

  86. MCEVOY JW
    Letter by McEvoy Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e20-e21.
    >> Share

  87. LEE H, Yano Y, Cho SMJ, Lloyd-Jones DM, et al
    Response by Lee et al to Letter Regarding Article, "Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults".
    Circulation. 2021;143:e22-e23.
    >> Share

  88. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    >> Share

  89. BOIS MC, Boire NA, Layman AJ, Aubry MC, et al
    COVID-19-Associated Nonocclusive Fibrin Microthrombi in the Heart.
    Circulation. 2021;143:230-243.
    >> Share

  90. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
    Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
    Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
    >> Share

  91. YOUNG JM, Sage JN, Pickering JW, Bannister L, et al
    Next-Day Troponin Tests in Real-World Implementation of Baseline Troponin Rule-Out of Myocardial Infarction Demonstrates Minimal Delayed Troponin Rises.
    Circulation. 2021;143:202-204.
    >> Share

  92. O'FEE K, Panza JA, Brown DL
    Association of Inducible Myocardial Ischemia With Long-Term Mortality and Benefit From Coronary Artery Bypass Graft Surgery in Ischemic Cardiomyopathy: Ten-Year Follow-Up of the STICH Trial.
    Circulation. 2021;143:205-207.
    >> Share

  93. KUEHN BM
    Pandemic Throws Cardiovascular Trials Off Course.
    Circulation. 2021;143:89-90.
    >> Share

    December 2020
  94. IGLESIAS JF, Valgimigli M, Carbone F, Lauriers N, et al
    Effects of Fentanyl Versus Morphine on Ticagrelor-Induced Platelet Inhibition in Patients With ST-Segment Elevation Myocardial Infarction: The PERSEUS Randomized Trial.
    Circulation. 2020;142:2479-2481.
    >> Share


  95. Correction to: Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020;142:e632.
    >> Share

  96. PAL N, Padala S, Klein K
    Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e501-e502.
    >> Share

  97. BELLEY-COTE EP, Whitlock RP
    Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e503.
    >> Share

  98. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
    Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
    Circulation. 2020;142:e504-e505.
    >> Share

  99. VLACHOJANNIS GJ, Wilschut JM, Vogel RF, Lemmert ME, et al
    Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.
    Circulation. 2020;142:2316-2328.
    >> Share

  100. DAVE CV, Kim SC, Goldfine AB, Glynn RJ, et al
    Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy.
    Circulation. 2020 Dec 11. doi: 10.1161/CIRCULATIONAHA.120.047965.
    >> Share

  101. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    >> Share

  102. ARNADOTTIR A, Pedersen S, Hasselbalch RB, Goetze JP, et al
    Temporal Release of High-Sensitivity Cardiac Troponin T and I and Copeptin After Brief Induced Coronary Artery Balloon Occlusion in Humans.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.046574.
    >> Share


  103. Correction to: Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association.
    Circulation. 2020;142:e449.
    >> Share

  104. MELHEM NJ, Chajadine M, Gomez I, Howangyin KY, et al
    Endothelial Cell Indoleamine 2, 3-Dioxygenase 1 Alters Cardiac Function Following Myocardial Infarction Through Kynurenine.
    Circulation. 2020 Dec 4. doi: 10.1161/CIRCULATIONAHA.120.050301.
    >> Share

  105. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
    Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
    >> Share

  106. CHAITMAN BR, Alexander KP, Cyr DD, Berger JS, et al
    Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.047987.
    >> Share

  107. FORAKER RE, Benziger CP, DeBarmore BM, Cene CW, et al
    Achieving Optimal Population Cardiovascular Health Requires an Interdisciplinary Team and a Learning Healthcare System: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Dec 3:CIR0000000000000913. doi: 10.1161/CIR.0000000000000913.
    >> Share

  108. LIANG T, Gao F, Jiang J, Lu YW, et al
    Loss of Phosphatase and Tensin Homolog Promotes Cardiomyocyte Proliferation and Cardiac Repair After Myocardial Infarction.
    Circulation. 2020;142:2196-2199.
    >> Share

  109. CAPODANNO D, Angiolillo DJ
    Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
    Circulation. 2020;142:2172-2188.
    >> Share

    November 2020
  110. EL KHOUDARY SR, Aggarwal B, Beckie TM, Hodis HN, et al
    Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Nov 30:CIR0000000000000912. doi: 10.1161/CIR.0000000000000912.
    >> Share

  111. EZEKOWITZ JA, Savu A, Welsh RC, McAlister FA, et al
    Is There a Sex Gap in Surviving an Acute Coronary Syndrome or Subsequent Development of Heart Failure?
    Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.048015.
    >> Share

  112. ARVANITIS M, Qi G, Bhatt DL, Post WS, et al
    A Linear and Non-Linear Mendelian Randomization Analysis of the Association Between Diastolic Blood Pressure and Cardiovascular Events: The J Curve Revisited.
    Circulation. 2020 Nov 30. doi: 10.1161/CIRCULATIONAHA.120.049819.
    >> Share

  113. SCHOEPFER H, Nestelberger T, Boeddinghaus J, Twerenbold R, et al
    Effect of a Proposed Modification of the Type 1 and Type 2 Myocardial Infarction Definition on Incidence and Prognosis.
    Circulation. 2020;142:2083-2085.
    >> Share


  114. Correction to: Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography After Cardiac Arrest Without ST-Segment Elevation: The PEARL Study.
    Circulation. 2020;142:e374.
    >> Share

  115. LEMKES JS
    Coronary Angiography After Cardiac Arrest: A Deep Dive for PEARL.
    Circulation. 2020;142:2013-2015.
    >> Share

  116. KIM HS, Kang J, Hwang D, Han JK, et al
    Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial.
    Circulation. 2020 Nov 18. doi: 10.1161/CIRCULATIONAHA.120.051700.
    >> Share

  117. ROUBILLE F, Tardif JC
    Colchicine for Secondary Cardiovascular Prevention in Coronary Disease.
    Circulation. 2020;142:1901-1904.
    >> Share

  118. SCIRICA BM, Cannon CP, Fisher NDL, Gaziano TA, et al
    Digital Care Transformation: Interim Report From the First 5000 Patients Enrolled in a Remote Algorithm-Based Cardiovascular Risk Management Program to Improve Lipid and Hypertension Control.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051913.
    >> Share

  119. RODRIGUEZ F, Solomon N, de Lemos JA, Das SR, et al
    Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.052278.
    >> Share

  120. HENDREN NS, de Lemos JA, Ayers C, Das SR, et al
    Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Circulation. 2020 Nov 17. doi: 10.1161/CIRCULATIONAHA.120.051936.
    >> Share

  121. PACKARD CJ
    Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Tr
    Circulation. 2020;142:e333-e334.
    >> Share

  122. WRIGHT AK, Suarez-Ortegon MF, Read SH, Kontopantelis E, et al
    Risk Factor Control and Cardiovascular Event Risk in People With Type 2 Diabetes in Primary and Secondary Prevention Settings.
    Circulation. 2020;142:1925-1936.
    >> Share

  123. SCHWARTZ GG, Szarek M, Bittner VA, Steg PG, et al
    Response by Schwartz et al to Letter Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Ran
    Circulation. 2020;142:e335-e336.
    >> Share

  124. FILIPPATOS G, Anker SD, Agarwal R, Pitt B, et al
    Finerenone and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes.
    Circulation. 2020 Nov 16. doi: 10.1161/CIRCULATIONAHA.120.051898.
    >> Share

  125. KALSTAD AA, Myhre PL, Laake K, Tveit SH, et al
    Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial.
    Circulation. 2020 Nov 15. doi: 10.1161/CIRCULATIONAHA.120.052209.
    >> Share

  126. CHERNEY DZI, McGuire DK, Charbonnel B, Cosentino F, et al
    Gradient of Risk and Associations with Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function: Observations from VERTIS CV.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051901.
    >> Share

  127. MCMURRAY JJV, Wheeler DC, Stefansson BV, Jongs N, et al
    Effect of Dapagliflozin on Clinical Outcomes in Patients with Chronic Kidney Disease, With and Without Cardiovascular Disease.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051675.
    >> Share

  128. SIMON JN, Vrellaku B, Monterisi S, Chu SM, et al
    Oxidation of Protein Kinase A Regulatory Subunit PKARIalpha Protects Against Myocardial Ischemia-Reperfusion Injury by Inhibiting Lysosomal-Triggered Calcium Release.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.046761.
    >> Share

  129. ANKER SD, Butler J, Filippatos G, Khan MS, et al
    Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial.
    Circulation. 2020 Nov 11. doi: 10.1161/CIRCULATIONAHA.120.051824.
    >> Share

  130. ALEXANDER JH, Smith PK
    Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1797-1798.
    >> Share

  131. ALBERT CL, Carmona-Rubio AE, Weiss AJ, Procop GG, et al
    The Enemy Within: Sudden-Onset Reversible Cardiogenic Shock With Biopsy-Proven Cardiac Myocyte Infection by Severe Acute Respiratory Syndrome Coronavirus 2.
    Circulation. 2020;142:1865-1870.
    >> Share

  132. PATEL KV, Bahnson JL, Gaussoin SA, Johnson KC, et al
    Association of Baseline and Longitudinal Changes in Body Composition Measures With Risk of Heart Failure and Myocardial Infarction in Type 2 Diabetes: Findings From the Look AHEAD Trial.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050941.
    >> Share

  133. VALVERDE I, Singh Y, Sanchez-de-Toledo J, Theocharis P, et al
    Acute Cardiovascular Manifestations in 286 Children with Multisystem Inflammatory Syndrome Associated with COVID-19 Infection in Europe.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.050065.
    >> Share

  134. HONIGBERG MC, Zekavat SM, Niroula A, Griffin GK, et al
    Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.
    Circulation. 2020 Nov 9. doi: 10.1161/CIRCULATIONAHA.120.051775.
    >> Share

  135. KAUFMAN JD, Elkind MSV, Bhatnagar A, Koehler K, et al
    Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association.
    Circulation. 2020 Nov 5:CIR0000000000000930. doi: 10.1161/CIR.0000000000000930.
    >> Share


  136. Correction to: Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Circulation. 2020;142:e316.
    >> Share

  137. KARIO K, Hoshide S, Mizuno H, Kabutoya T, et al
    Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
    Circulation. 2020 Nov 2. doi: 10.1161/CIRCULATIONAHA.120.049730.
    >> Share

    October 2020
  138. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    >> Share

  139. LOWENSTEIN CJ, Solomon SD
    Severe COVID-19 Is a Microvascular Disease.
    Circulation. 2020;142:1609-1611.
    >> Share

  140. NASLUND E, Stenberg E, Hofmann R, Ottosson J, et al
    Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Severe Obesity: A Nationwide Cohort Study.
    Circulation. 2020 Oct 26. doi: 10.1161/CIRCULATIONAHA.120.048585.
    >> Share

  141. WILLIAMS MC, Newby DE, Dey D, Dweck MR, et al
    Response by Williams et al to Letter Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the
    Circulation. 2020;142:e244-e245.
    >> Share

  142. ALFONSO F, Cecconi A, Jimenez-Borreguero J
    Letter by Alfonso et al Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the Heart)".
    Circulation. 2020;142:e242-e243.
    >> Share

  143. SIONTIS GCM, Raber L
    Letter by Siontis and Raber Regarding Article, "Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)".
    Circulation. 2020;142:e240-e241.
    >> Share

  144. NOLAN JP, Maconochie I, Soar J, Olasveengen TM, et al
    Executive Summary: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  145. MORLEY PT, Atkins DL, Finn JC, Maconochie I, et al
    Evidence Evaluation Process and Management of Potential Conflicts of Interest: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  146. GREIF R, Bhanji F, Bigham BL, Bray J, et al
    Education, Implementation, and Teams: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  147. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
    Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  148. WYCKOFF MH, Wyllie J, Aziz K, de Almeida MF, et al
    Neonatal Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  149. OLASVEENGEN TM, Mancini ME, Perkins GD, Avis S, et al
    Adult Basic Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  150. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
    Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2020;142.
    >> Share

  151. MERCHANT RM, Topjian AA, Panchal AR, Cheng A, et al
    Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  152. PANCHAL AR, Bartos JA, Cabanas JG, Donnino MW, et al
    Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  153. AZIZ K, Lee HC, Escobedo MB, Hoover AV, et al
    Part 5: Neonatal Resuscitation: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  154. CHENG A, Magid DJ, Auerbach M, Bhanji F, et al
    Part 6: Resuscitation Education Science: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  155. TOPJIAN AA, Raymond TT, Atkins D, Chan M, et al
    Part 4: Pediatric Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  156. MAGID DJ, Aziz K, Cheng A, Hazinski MF, et al
    Part 2: Evidence Evaluation and Guidelines Development: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  157. BERG KM, Cheng A, Panchal AR, Topjian AA, et al
    Part 7: Systems of Care: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2020;142.
    >> Share

  158. MURTHY VL, Reis JP, Pico AR, Kitchen R, et al
    Comprehensive Metabolic Phenotyping Refines Cardiovascular Risk in Young Adults.
    Circulation. 2020 Oct 19. doi: 10.1161/CIRCULATIONAHA.120.047689.
    >> Share

  159. SHAH P, deFilippi CR, Mullins KE
    Navigating COVID-19 Testing, Special Considerations for the Cardiovascular Clinician.
    Circulation. 2020 Oct 16. doi: 10.1161/CIRCULATIONAHA.120.051183.
    >> Share

  160. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
    Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.
    >> Share

  161. MYHRE PL, Prebensen C, Strand H, Roysland R, et al
    Growth Differentiation Factor-15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized with COVID-19.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050360.
    >> Share


  162. Correction to: Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Circulation. 2020;142:e234.
    >> Share


  163. Correction to: Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
    Circulation. 2020;142:e236.
    >> Share


  164. Correction to: Targeted Cardiac Overexpression of A20 Improves Left Ventricular Performance and Reduces Compensatory Hypertrophy After Myocardial Infarction.
    Circulation. 2020;142:e238.
    >> Share

  165. WANG TJ
    The Evolution of the Cardiovascular Biomarker Study.
    Circulation. 2020;142:1422-1424.
    >> Share

  166. FRANCHI F, Rollini F, Been L, Briceno M, et al
    Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention
    Circulation. 2020;142:1500-1502.
    >> Share

  167. MSZAR R, Nasir K, Santos RD
    Coronary Artery Calcification in Familial Hypercholesterolemia: An Opportunity for Risk Assessment and Shared Decision Making With the Power of Zero?
    Circulation. 2020;142:1405-1407.
    >> Share

  168. CACERES BA, Streed CG Jr, Corliss HL, Lloyd-Jones DM, et al
    Assessing and Addressing Cardiovascular Health in LGBTQ Adults: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Oct 8:CIR0000000000000914. doi: 10.1161/CIR.0000000000000914.
    >> Share

  169. COSENTINO F, Cannon CP, Cherney DZI, Masiukiewicz U, et al
    Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients with Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.
    Circulation. 2020 Oct 7. doi: 10.1161/CIRCULATIONAHA.120.050255.
    >> Share

  170. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    >> Share

  171. DUNN AN, Donnellan E, Johnston DR, Alashi A, et al
    Long-Term Outcomes of Patients With Mediastinal Radiation-Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.
    Circulation. 2020;142:1399-1401.
    >> Share

  172. RUEL M, Gardner T, Fischbein M, de Lemos J, et al
    Introduction to the 2020 Circulation Cardiovascular Surgery-Themed Issue.
    Circulation. 2020;142:1313-1314.
    >> Share

  173. LYTLE B, Gaudino M
    Fractional Flow Reserve for Coronary Artery Bypass Surgery.
    Circulation. 2020;142:1315-1316.
    >> Share

  174. OHBE H, Goto T, Miyamoto Y, Yasunaga H, et al
    Risk of Cardiovascular Events After Spouse's ICU Admission.
    Circulation. 2020 Oct 5. doi: 10.1161/CIRCULATIONAHA.120.047873.
    >> Share

  175. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    >> Share

    September 2020
  176. ZUREK M, Johansson E, Palmer M, Albery T, et al
    Neuregulin-1 Induces Cardiac Hypertrophy and Impairs Cardiac Performance in Post-Myocardial Infarction Rats.
    Circulation. 2020;142:1308-1311.
    >> Share

  177. XIA N, Lu Y, Gu M, Li N, et al
    A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection from Myocardial Infarction.
    Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.046789.
    >> Share

  178. KERN KB, Radsel P, Jentzer JC, Seder DB, et al
    A Randomized Pilot Clinical Trial of Early Coronary Angiography Versus No Early Coronary Angiography for Post-Cardiac Arrest Patients Without ST-Segment Elevation: The PEARL Study.
    Circulation. 2020 Sep 28. doi: 10.1161/CIRCULATIONAHA.120.049569.
    >> Share

  179. RUIZ-VILLALBA A, Romero JP, Hernandez SC, Vilas-Zornoza A, et al
    Single-Cell RNA-seq Analysis Reveals a Crucial Role for Collagen Triple Helix Repeat Containing 1 (CTHRC1) Cardiac Fibroblasts after Myocardial Infarction.
    Circulation. 2020 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.044557.
    >> Share

  180. MALESZEWSKI JJ, Young PM, Ackerman MJ, Halushka MK, et al
    An Urgent Need for Studies of the Late Effects of SARS-CoV-2 on the Cardiovascular System.
    Circulation. 2020 Sep 24. doi: 10.1161/CIRCULATIONAHA.120.051362.
    >> Share

  181. CUSHMAN M, Shay CM, Howard VJ, Jimenez MC, et al
    Ten-Year Differences in Women's Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association.
    Circulation. 2020 Sep 21:CIR0000000000000907. doi: 10.1161/CIR.0000000000000907.
    >> Share

  182. PETERS SAE, Colantonio LD, Dai Y, Zhao H, et al
    Trends in Recurrent Coronary Heart Disease Following Myocardial Infarction Among US Women and Men Between 2008 and 2017.
    Circulation. 2020 Sep 21. doi: 10.1161/CIRCULATIONAHA.120.047065.
    >> Share

  183. KLASSEN SL, Kwan GF, Bukhman G
    The COVID-19 pandemic: a massive threat for those living with cardiovascular disease among the poorest billion.
    Circulation. 2020 Sep 18. doi: 10.1161/CIRCULATIONAHA.120.047969.
    >> Share

  184. KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
    Response by Khosrow-Khavar et al to Letters Regarding Article, "Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study".
    Circulation. 2020;142:e158-e159.
    >> Share

  185. REN C, Li P, Chen HZ
    Letter by Ren et al Regarding Article, "Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study".
    Circulation. 2020;142:e156-e157.
    >> Share

  186. KIZAWA R, Hara T, Miura Y
    Letter by Kizawa et al Regarding Article, "Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study".
    Circulation. 2020;142:e154-e155.
    >> Share

  187. OMLAND T, Prebensen C, Roysland R, Sovik S, et al
    Established Cardiovascular Biomarkers Provide Limited Prognostic Information in Unselected Patients Hospitalized with COVID-19.
    Circulation. 2020 Sep 10. doi: 10.1161/CIRCULATIONAHA.120.050089.
    >> Share

  188. VERSTRAETEN A, Perik MHAM, Baranowska AA, Meester JAN, et al
    Enrichment of Rare Variants in Loeys-Dietz Syndrome Genes in Spontaneous Coronary Artery Dissection but Not in Severe Fibromuscular Dysplasia.
    Circulation. 2020;142:1021-1024.
    >> Share

  189. HUSSAIN A, Ballantyne CM, Nambi V
    Zero Coronary Artery Calcium Score: Desirable, but Enough?
    Circulation. 2020;142:917-919.
    >> Share

  190. CHAN MY, Efthymios M, Tan SH, Pickering JW, et al
    Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Circulation. 2020 Sep 4. doi: 10.1161/CIRCULATIONAHA.119.045158.
    >> Share

  191. JACOBSEN AP, Raber I, McCarthy CP, Blumenthal RS, et al
    Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or is Reappraisal Warranted?
    Circulation. 2020 Sep 4. doi: 10.1161/CIRCULATIONAHA.120.045695.
    >> Share

  192. CAPRANZANO P, Angiolillo DJ
    Ticagrelor or Clopidogrel in Elderly Patients with Myocardial Infarction: When the Choice Makes the Difference.
    Circulation. 2020 Sep 1. doi: 10.1161/CIRCULATIONAHA.120.050845.
    >> Share

  193. SREEJIT G, Nagareddy PR
    Response by Sreejit and Nagareddy to Letter Regarding Article, "Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction".
    Circulation. 2020;142:e125-e126.
    >> Share

  194. WANG D, Wang T, Yang X
    Letter by Wang et al Regarding Article, "Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction".
    Circulation. 2020;142:e123-e124.
    >> Share

  195. SZUMMER K, Montez-Rath ME, Alfredsson J, Erlinge D, et al
    Comparison Between Ticagrelor and Clopidogrel in Elderly Patients with an Acute Coronary Syndrome: Insights from the SWEDEHEART Registry.
    Circulation. 2020 Sep 1. doi: 10.1161/CIRCULATIONAHA.120.050645.
    >> Share

  196. WIERZBICKI AS
    Phenomics, Not Genomics, for Cardiovascular Risk Assessment.
    Circulation. 2020;142:821-823.
    >> Share

  197. LEENING MJG
    Who Benefits From Taking a Statin, and When?: On Fundamentally Restructuring Our Thinking Regarding Primary Prevention of Cardiovascular Disease.
    Circulation. 2020;142:838-840.
    >> Share

    August 2020
  198. OPSTAL TSJ, Hoogeveen RM, Fiolet ATL, Silvis MJM, et al
    Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy.
    Circulation. 2020 Aug 31. doi: 10.1161/CIRCULATIONAHA.120.050560.
    >> Share

  199. WILLEMSEN LM, Janssen PWA, Peper J, Soliman-Hamad MA, et al
    The Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Circulation. 2020 Aug 31. doi: 10.1161/CIRCULATIONAHA.120.050749.
    >> Share

  200. LOPES RD, Alexander KP, Stevens SR, Reynolds HR, et al
    Initial Invasive versus Conservative Management of Stable Ischemic Heart Disease Patients with a History of Heart Failure or Left Ventricular Dysfunction: Insights from the ISCHEMIA Trial.
    Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050304.
    >> Share

  201. MORDI NA, Mordi IR, Singh JS, McCrimmon RJ, et al
    Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination with Loop Diuretics in Patients with Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.048739.
    >> Share

  202. TONG DC, Quinn S, Nasis A, Hiew C, et al
    Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
    Circulation. 2020 Aug 29. doi: 10.1161/CIRCULATIONAHA.120.050771.
    >> Share

  203. KRONISH IM, Cornelius T, Schwartz JE, Shechter A, et al
    Posttraumatic Stress Disorder and Electronically Measured Medication Adherence After Suspected Acute Coronary Syndromes.
    Circulation. 2020;142:817-819.
    >> Share

  204. HORIUCHI Y, Wettersten N, Patel MP, Mueller C, et al
    Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Circulation. 2020 Aug 21. doi: 10.1161/CIRCULATIONAHA.120.046682.
    >> Share

  205. HILL JA, Albert MA, Carnethon MR, Watson KE, et al
    Disparities in Cardiovascular Medicine: Circulation's Response.
    Circulation. 2020 Aug 19. doi: 10.1161/CIRCULATIONAHA.120.050670.
    >> Share

  206. SHAH PK
    Does Reduced Carotid Intima Media Thickness Progression Predict Cardiovascular Risk Reduction?
    Circulation. 2020;142:643-644.
    >> Share

  207. TUCKER NR, Chaffin M, Bedi KC Jr, Papangeli I, et al
    Myocyte-Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2-Mediated Myocarditis.
    Circulation. 2020;142:708-710.
    >> Share

  208. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e76-e77.
    >> Share

  209. VINCENT F, Van Belle E, Susen S
    Letter by Vincent et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e80-e81.
    >> Share

  210. O'NEILL WW, Burkhoff D
    Letter by O'Neill and Burkhoff Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e78-e79.
    >> Share

  211. HELGESTAD OKL, Moller S, Moller JE
    Letter by Helgestad et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e72-e73.
    >> Share

  212. AMIN AP, Rao SV, Bach RG, Curtis JP, et al
    Response by Amin et al to Letters Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e82-e84.
    >> Share

  213. CHIEFFO A, Gramegna M, Pappalardo F
    Letter by Chieffo et al Regarding Article, "The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support".
    Circulation. 2020;142:e74-e75.
    >> Share

  214. MYHRE PL, Grundvold I, Paulsen TH, Omland T, et al
    Cardiovascular Hospitalizations, Influenza Activity and COVID-19 Measures.
    Circulation. 2020 Aug 6. doi: 10.1161/CIRCULATIONAHA.120.049118.
    >> Share

  215. PAGE RL 2ND, Allen LA, Kloner RA, Carriker CR, et al
    Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Aug 5:CIR0000000000000883. doi: 10.1161/CIR.0000000000000883.
    >> Share

  216. GARGIULO G, Esposito G, Avvedimento M, Nagler M, et al
    Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:441-454.
    >> Share


  217. Correction to: Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial.
    Circulation. 2020;142:e71.
    >> Share

  218. KHAN SU, Singh M, Valavoor S, Khan MU, et al
    Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.
    Circulation. 2020 Aug 3. doi: 10.1161/CIRCULATIONAHA.120.046308.
    >> Share

    July 2020
  219. PENCINA M, Pencina K, Lloyd-Jones D, Catapano AL, et al
    The Expected 30-year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering.
    Circulation. 2020 Jul 23. doi: 10.1161/CIRCULATIONAHA.120.045851.
    >> Share

  220. FARIDI KF, Tamez H, Strom JB, Song Y, et al
    Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.
    Circulation. 2020;142:306-308.
    >> Share


  221. Temporary Emergency Guidance to STEMI Systems of Care During the COVID-19 Pandemic: AHA's Mission: Lifeline.
    Circulation. 2020;142:199-202.
    >> Share

  222. GUAGLIUMI G, Sonzogni A, Pescetelli I, Pellegrini D, et al
    Microthrombi and ST-Segment Elevation Myocardial Infarction in COVID-19.
    Circulation. 2020 Jul 17. doi: 10.1161/CIRCULATIONAHA.120.049294.
    >> Share

  223. MESSERLI FH, Siontis GCM, Raber L
    Letter by Messerli et al Regarding Article, "Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort".
    Circulation. 2020;142:e27-e28.
    >> Share

  224. RAPHAEL CE, Roger VL, Sandoval Y, Singh M, et al
    Response by Raphael et al to the Letters Regarding Article, "Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort".
    Circulation. 2020;142:e29-e30.
    >> Share

  225. SCHOEPFER H, Nestelberger T, Mueller C
    Letter by Schoepfer et al Regarding Article, "Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort".
    Circulation. 2020;142:e25-e26.
    >> Share


  226. Correction to: Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak.
    Circulation. 2020;142:e32.
    >> Share


  227. Correction to: Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Ticagrelor-Induced Platelet Inhibition in Acute Myocardial Infarction: The Randomized MonAMI Trial.
    Circulation. 2020;142:e24.
    >> Share

  228. KORNOWSKI R, Orvin K
    Current Status of Cardiovascular Medicine in Israel.
    Circulation. 2020;142:17-19.
    >> Share

    June 2020
  229. BANGALORE S, Maron DJ, Stone GW, Hochman JS, et al
    Routine Revascularization versus Initial Medical Therapy for Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Circulation. 2020 Jun 26. doi: 10.1161/CIRCULATIONAHA.120.048194.
    >> Share

  230. ZHANG Y, Chen C, Sun Z, Ma R, et al
    Associations Between Short-Term Exposure to Fine Particulate Matter and Cardiovascular Disease Hospital Admission After Index Myocardial Infarction: A Case-Crossover Study.
    Circulation. 2020;141:2110-2112.
    >> Share

  231. COLLERAN R, Byrne RA
    Polymer-Free Drug-Eluting Stents: The Importance of the Right Control.
    Circulation. 2020;141:2064-2066.
    >> Share

  232. O'DONOGHUE ML, Murphy SA, Sabatine MS
    The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12 Inhibitor in Patients after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Circulation. 2020 Jun 19. doi: 10.1161/CIRCULATIONAHA.120.046251.
    >> Share

  233. WILLEIT P, Tschiderer L, Allara E, Reuber K, et al
    Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients.
    Circulation. 2020 Jun 17. doi: 10.1161/CIRCULATIONAHA.120.046361.
    >> Share

  234. CHANDRASHEKHAR Y, Alexander T, Mullasari A, Kumbhani DJ, et al
    Resource and Infrastructure-Appropriate Management of ST-Segment Elevation Myocardial Infarction in Low- and Middle-Income Countries.
    Circulation. 2020;141:2004-2025.
    >> Share

  235. ZHANG L, Zlotoff DA, Awadalla M, Mahmood SS, et al
    Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
    Circulation. 2020;141:2031-2034.
    >> Share

  236. ROFFI M, Guagliumi G, Ibanez B
    The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic.
    Circulation. 2020;141:1951-1953.
    >> Share

  237. DANIELS MJ, Cohen MG, Bavry AA, Kumbhani DJ, et al
    Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?
    Circulation. 2020;141:1948-1950.
    >> Share

  238. MOAZZAMI K, Wittbrodt MT, Lima BB, Nye JA, et al
    Higher Activation of the Rostromedial Prefrontal Cortex during Mental Stress Predicts Major Cardiovascular Disease Events in Individuals with Coronary Artery Disease.
    Circulation. 2020 Jun 11. doi: 10.1161/CIRCULATIONAHA.119.044442.
    >> Share

  239. COSCIA T, Nestelberger T, Mueller C
    Letter by Coscia et al Regarding Article, "High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction".
    Circulation. 2020;141:e880-e881.
    >> Share

  240. WERESKI R, Mills NL, Chapman AR
    Response by Wereski et al to Letter Regarding Article, "High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction".
    Circulation. 2020;141:e882-e883.
    >> Share


  241. Correction to: Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI).
    Circulation. 2020;141:e905.
    >> Share


  242. Correction to: Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2020;141:e904.
    >> Share

  243. EBERLY LA, Khatana SAM, Nathan AS, Snider C, et al
    Telemedicine Outpatient Cardiovascular Care during the COVID-19 Pandemic: Bridging or Opening the Digital Divide?
    Circulation. 2020 Jun 8. doi: 10.1161/CIRCULATIONAHA.120.048185.
    >> Share

  244. KOLPAKOV MA, Guo X, Rafiq K, Vlasenko L, et al
    Loss of Protease-Activated Receptor 4 Prevents Inflammation Resolution and Predisposes the Heart to Cardiac Rupture after Myocardial Infarction.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044340.
    >> Share

  245. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
    Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
    >> Share

  246. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    >> Share

  247. CHAPMAN AR, Bularga A, Mills NL
    High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19.
    Circulation. 2020;141:1733-1735.
    >> Share

  248. SELVARAJ S, Kelly DP, Margulies KB
    Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Circulation. 2020;141:1800-1812.
    >> Share

    May 2020
  249. NAVARESE EP, Khan SU, Kolodziejczak M, Kubica J, et al
    Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52,816 Patients from 12 Randomized Trials.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.120.046786.
    >> Share

  250. HU P, Dharmayat KI, Stevens CAT, Sharabiani MTA, et al
    Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Circulation. 2020 May 29. doi: 10.1161/CIRCULATIONAHA.119.044795.
    >> Share

  251. BREATHETT K, Sims M, Gross M, Jackson EA, et al
    Cardiovascular Health in American Indians and Alaska Natives: A Scientific Statement From the American Heart Association.
    Circulation. 2020 May 28:CIR0000000000000773. doi: 10.1161/CIR.0000000000000773.
    >> Share

  252. NGUYEN LS, Dolladille C, Drici MD, Fenioux C, et al
    Cardiovascular Toxicities Associated with Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.120.048238.
    >> Share

  253. JENSEN LO, Maeng M, Raungaard B, Kahlert J, et al
    Randomised Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent with the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated with Percutaneous Coronary Intervention: The SORT OUT IX Trial
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.119.040241.
    >> Share

  254. PANDEY A, Keshvani N, Vaughan-Sarrazin MS, Gao Y, et al
    Evaluation of Risk-Adjusted Home Time After Acute Myocardial Infarction as a Novel Hospital-Level Performance Metric for Medicare Beneficiaries.
    Circulation. 2020 May 15. doi: 10.1161/CIRCULATIONAHA.119.044765.
    >> Share

  255. NAGELE P
    A Simplified Proposal to Redefine Acute Myocardial Infarction Versus Acute Myocardial Injury.
    Circulation. 2020;141:1431-1433.
    >> Share

  256. SANDOVAL Y, Thygesen K, Jaffe AS
    The Universal Definition of Myocardial Infarction: Present and Future.
    Circulation. 2020;141:1434-1436.
    >> Share

  257. KOHLI P, Virani SS
    Surfing the Waves of the COVID-19 Pandemic As A Cardiovascular Clinician.
    Circulation. 2020 May 5. doi: 10.1161/CIRCULATIONAHA.120.047901.
    >> Share

  258. MEHTA LS, Warnes CA, Bradley E, Burton T, et al
    Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2020 May 4:CIR0000000000000772. doi: 10.1161/CIR.0000000000000772.
    >> Share

    April 2020
  259. STEFANINI GG, Montorfano M, Trabattoni D, Andreini D, et al
    ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.047525.
    >> Share

  260. PICCOLO R, Bruzzese D, Mauro C, Aloia A, et al
    Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19 Outbreak.
    Circulation. 2020 Apr 30. doi: 10.1161/CIRCULATIONAHA.120.047457.
    >> Share

  261. ARMSTRONG PW
    Enhancing Cardiovascular Care: Global Collaboration Is How It Happens.
    Circulation. 2020;141:1357-1359.
    >> Share

  262. LI L, Li H, Tien CL, Jain MK, et al
    Kruppel-Like Factor 15 Regulates the Circadian Susceptibility to Ischemia Reperfusion Injury in the Heart.
    Circulation. 2020;141:1427-1429.
    >> Share

  263. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
    Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
    Circulation. 2020;141:1360-1370.
    >> Share

  264. SAAD M, Meyer-Saraei R, de Waha-Thiele S, Stiermaier T, et al
    Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Ticagrelor-Induced Platelet Inhibition in Acute Myocardial Infarction: The Randomized MonAMI Trial.
    Circulation. 2020;141:1354-1356.
    >> Share

  265. ZHOU H, Zhao YT
    Anterior ST-Segment Elevation Myocardial Infarction Without ST Elevation in Lead V1: Where Is the Culprit Lesion?
    Circulation. 2020;141:1351-1353.
    >> Share


  266. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e773.
    >> Share

  267. ARAI AE, Hsu LY
    Global Developments in Stress Perfusion Cardiovascular Magnetic Resonance.
    Circulation. 2020;141:1292-1294.
    >> Share

  268. AENGEVAEREN VL, Mosterd A, Sharma S, Prakken NHJ, et al
    Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management.
    Circulation. 2020;141:1338-1350.
    >> Share


  269. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e774.
    >> Share

  270. VETROVEC G, Stravitz RT
    Bleeding in Patients With Cirrhosis Undergoing Invasive Cardiovascular Procedures: Do We Overestimate Risk?
    Circulation. 2020;141:1279-1281.
    >> Share

  271. KNOTT KD, Seraphim A, Augusto JB, Xue H, et al
    The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence-Based Approach Using Perfusion Mapping.
    Circulation. 2020;141:1282-1291.
    >> Share

  272. SPERLING LS
    The Future of Cardiovascular Prevention: Unprecedented Times.
    Circulation. 2020 Apr 20. doi: 10.1161/CIRCULATIONAHA.120.047059.
    >> Share

  273. DUFFY EY, Cainzos-Achirica M, Michos ED
    Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic.
    Circulation. 2020 Apr 20. doi: 10.1161/CIRCULATIONAHA.120.047194.
    >> Share

  274. ZHOU X, Li Y, Yang Q
    Antiplatelet Therapy Following Percutaneous Coronary Intervention in Patients Complicated by COVID-19: Implications from Clinical Features to Pathological Findings.
    Circulation. 2020 Apr 16. doi: 10.1161/CIRCULATIONAHA.120.046988.
    >> Share

  275. HENDREN NS, Drazner MH, Bozkurt B, Cooper LT Jr, et al
    Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Circulation. 2020 Apr 16. doi: 10.1161/CIRCULATIONAHA.120.047349.
    >> Share

  276. LIU PP, Blet A, Smyth D, Li H, et al
    The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Circulation. 2020 Apr 15. doi: 10.1161/CIRCULATIONAHA.120.047549.
    >> Share

  277. ORTEGA-PAZ L, Brugaletta S, Gomez-Lara J, Sabate M, et al
    Response by Ortega-Paz et al to Letter Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
    Circulation. 2020;141:e748-e749.
    >> Share

  278. CONSUEGRA-SANCHEZ L, Ong P, Kaski JC
    Letter by Consuegra-Sanchez et al Regarding Article, "Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial".
    Circulation. 2020;141:e746-e747.
    >> Share

  279. CLIMIE RE, Marques FZ
    Impact, Strategies and Opportunities for Early and Mid-Career Cardiovascular Researchers During the COVID-19 Pandemic.
    Circulation. 2020 Apr 14. doi: 10.1161/CIRCULATIONAHA.120.047394.
    >> Share

  280. KOJIMA Y, Ye J, Nanda V, Wang Y, et al
    Knockout of the Murine Ortholog to the Human 9p21 Coronary Artery Disease Locus Leads to Smooth Muscle Cell Proliferation, Vascular Calcification, and Advanced Atherosclerosis.
    Circulation. 2020;141:1274-1276.
    >> Share

  281. JIANG M, Knight BP, Verma N
    Conduction Abnormalities and Ischemic Cardiomyopathy in an 84-Year-Old Man.
    Circulation. 2020;141:1268-1270.
    >> Share

  282. ARNOLD SV, Bhatt DL, Barsness GW, Beatty AL, et al
    Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Apr 13:CIR0000000000000766. doi: 10.1161/CIR.0000000000000766.
    >> Share

  283. EDELSON DP, Sasson C, Chan PS, Atkins DL, et al
    Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines((R))-Resuscitation Adult and Pediatric Task Force
    Circulation. 2020 Apr 9. doi: 10.1161/CIRCULATIONAHA.120.047463.
    >> Share

  284. PARK JH, Kim DH, Park YG, Kwon DY, et al
    Association of Parkinson Disease With Risk of Cardiovascular Disease and All-Cause Mortality: A Nationwide, Population-Based Cohort Study.
    Circulation. 2020;141:1205-1207.
    >> Share

  285. PARK DW, Park SJ
    Response by Park and Park to Letter Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial".
    Circulation. 2020;141:e741-e742.
    >> Share

  286. CHEN ZQ, Chen F, Li L
    Letter by Chen et al Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial".
    Circulation. 2020;141:e739-e740.
    >> Share

  287. ROSENGREN A, Wallentin L
    Cardiovascular Medicine in Sweden: Improvement by Continuous Measuring.
    Circulation. 2020;141:1124-1126.
    >> Share

  288. KIM Y, Johnson TW, Jeong MH
    Letter by Kim et al Regarding Article, "Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial".
    Circulation. 2020;141:e737-e738.
    >> Share

  289. VIRANI SS, Smith SC Jr, Stone NJ, Grundy SM, et al
    Secondary Prevention for Atherosclerotic Cardiovascular Disease: Comparing Recent US and European Guidelines on Dyslipidemia.
    Circulation. 2020;141:1121-1123.
    >> Share

  290. CARNETHON MR, Khan SS
    A Feast of Observations About Diet.
    Circulation. 2020;141:1138-1140.
    >> Share

  291. SAXENA A, Garan AR, Kapur NK, O'Neill WW, et al
    Value of Hemodynamic Monitoring in Patients With Cardiogenic Shock Undergoing Mechanical Circulatory Support.
    Circulation. 2020;141:1184-1197.
    >> Share

  292. FRIED JA, Ramasubbu K, Bhatt R, Topkara VK, et al
    The Variety of Cardiovascular Presentations of COVID-19.
    Circulation. 2020 Apr 3. doi: 10.1161/CIRCULATIONAHA.120.047164.
    >> Share

  293. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Al Rifai M, et al
    Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2020 Apr 1. doi: 10.1161/CIRCULATIONAHA.119.045010.
    >> Share

    March 2020
  294. DEMPSEY PC, Strain T, Khaw KT, Wareham NJ, et al
    Prospective Associations of Accelerometer-Measured Physical Activity and Sedentary Time With Incident Cardiovascular Disease, Cancer, and All-Cause Mortality.
    Circulation. 2020;141:1113-1115.
    >> Share

  295. PARK DW, Ahn JM, Park H, Yun SC, et al
    Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046039.
    >> Share

  296. ALFONSO F, Kastrati A
    Ten-Year Follow-Up of Left Main Coronary Artery Revascularization: Still Equipoise Between Percutaneous Interventions and Surgery?
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.120.046154.
    >> Share

  297. ALAHMAD B, Khraishah H, Shakarchi AF, Albaghdadi M, et al
    Cardiovascular Mortality and Exposure to Heat in an Inherently Hot Region: Implications for Climate Change.
    Circulation. 2020 Mar 30. doi: 10.1161/CIRCULATIONAHA.119.044860.
    >> Share

  298. SCHWARTZ GG, Steg PG, Szarek M, Bittner VA, et al
    Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046524.
    >> Share

  299. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    >> Share

  300. BHATT DL, Eikelboom JW, Connolly SJ, Steg PG, et al
    The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial.
    Circulation. 2020 Mar 28. doi: 10.1161/CIRCULATIONAHA.120.046448.
    >> Share

  301. HAN Y, Zeng H, Jiang H, Yang Y, et al
    CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic.
    Circulation. 2020 Mar 27. doi: 10.1161/CIRCULATIONAHA.120.047011.
    >> Share

  302. MA L, Liu G, Ding M, Zong G, et al
    Isoflavone Intake and the Risk of Coronary Heart Disease in US Men and Women: Results From 3 Prospective Cohort Studies.
    Circulation. 2020 Mar 23. doi: 10.1161/CIRCULATIONAHA.119.041306.
    >> Share

  303. CLERKIN KJ, Fried JA, Raikhelkar J, Sayer G, et al
    Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease.
    Circulation. 2020 Mar 21. doi: 10.1161/CIRCULATIONAHA.120.046941.
    >> Share

  304. BAINEY KR, Welsh RC, Connolly SJ, Marsden T, et al
    Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients with Prior Percutaneous Coronary Intervention (COMPASS-PCI).
    Circulation. 2020 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.044598.
    >> Share

  305. SORRENTINO S, Claessen BE, Chandiramani R, Guedeney P, et al
    Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Circulation. 2020;141:891-901.
    >> Share

  306. WILLIAMS MC, Kwiecinski J, Doris M, McElhinney P, et al
    Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART).
    Circulation. 2020 Mar 16. doi: 10.1161/CIRCULATIONAHA.119.044720.
    >> Share

  307. REDDY KS, Prabhakaran D
    Reducing the Risk of Cardiovascular Disease: Brick by BRICS.
    Circulation. 2020;141:800-802.
    >> Share

  308. TSUDA K
    Letter by Tsuda Regarding Article, "Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial".
    Circulation. 2020;141:e100-e101.
    >> Share

    February 2020
  309. KUHN TC, Knobel J, Burkert-Rettenmaier S, Li X, et al
    Secretome Analysis of Cardiomyocytes Identifies PCSK6 as a Novel Player in Cardiac Remodeling After Myocardial Infarction.
    Circulation. 2020 Feb 26. doi: 10.1161/CIRCULATIONAHA.119.044914.
    >> Share

  310. FRANKLIN BA, Thompson PD, Al-Zaiti SS, Albert CM, et al
    Exercise-Related Acute Cardiovascular Events and Potential Deleterious Adaptations Following Long-Term Exercise Training: Placing the Risks Into Perspective-An Update: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Feb 26:CIR0000000000000749. doi: 10.1161/CIR.0000000000000749.
    >> Share

  311. KAYE DM, Shihata W, Jama HA, Tsyganov K, et al
    Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease.
    Circulation. 2020 Feb 25. doi: 10.1161/CIRCULATIONAHA.119.043081.
    >> Share

  312. LEVIN MG, Rader DJ
    Polygenic Risk Scores and Coronary Artery Disease: Ready for Prime Time?
    Circulation. 2020;141:637-640.
    >> Share

  313. KAZMIRCZAK F, Martin CM, Shenoy C
    Left Ventricular Noncompaction and Cardiogenic Shock.
    Circulation. 2020;141:696-701.
    >> Share

  314. MEFFORD MT, Li BH, Qian L, Reading SR, et al
    Sex-Specific Trends in Acute Myocardial Infarction Within an Integrated Healthcare Network, 2000 Through 2014.
    Circulation. 2020;141:509-519.
    >> Share

  315. XIA S, Du X, Guo L, Du J, et al
    Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China.
    Circulation. 2020;141:530-539.
    >> Share

  316. CASADEI B, Rutherford JD
    Building a Career in Cardiovascular Research: A Conversation With Barbara Casadei, MD, DPhil.
    Circulation. 2020;141:504-508.
    >> Share

  317. AGARWALA A, Michos ED, Samad Z, Ballantyne CM, et al
    The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.
    Circulation. 2020;141:592-599.
    >> Share

  318. KHOSROW-KHAVAR F, Filion KB, Bouganim N, Suissa S, et al
    Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
    Circulation. 2020;141:549-559.
    >> Share

  319. JIN X, Chandramouli C, Allocco B, Gong E, et al
    Women's Participation in Cardiovascular Clinical Trials From 2010 to 2017.
    Circulation. 2020;141:540-548.
    >> Share

  320. KUWABARA M, Sasaki J, Saikawa T, Ouchi Y, et al
    Response by Kuwabara et al to Letter Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial".
    Circulation. 2020;141:e67-e68.
    >> Share

  321. WEINGARTNER O, Sijbrands E, Lutjohann D
    Letter by Weingartner et al Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial".
    Circulation. 2020;141:e65-e66.
    >> Share

  322. HEUSCH G, Gersh BJ
    Is Cardioprotection Salvageable?
    Circulation. 2020;141:415-417.
    >> Share

  323. KOCIOL RD, Cooper LT, Fang JC, Moslehi JJ, et al
    Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.
    Circulation. 2020;141:e69-e92.
    >> Share

  324. BHATT DL, Miller M, Brinton EA, Jacobson TA, et al
    REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States.
    Circulation. 2020;141:367-375.
    >> Share

    January 2020
  325. HADAS Y, Vincek AS, Youssef E, Zak MM, et al
    Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response after Myocardial Infarction.
    Circulation. 2020 Jan 29. doi: 10.1161/CIRCULATIONAHA.119.041882.
    >> Share

  326. SHARMA A, Pagidipati NJ, Califf RM, McGuire DK, et al
    Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
    Circulation. 2020 Jan 29. doi: 10.1161/CIRCULATIONAHA.119.041022.
    >> Share

  327. ROGER VL, Sidney S, Fairchild AL, Howard VJ, et al
    Recommendations for Cardiovascular Health and Disease Surveillance for 2030 and Beyond: A Policy Statement From the American Heart Association.
    Circulation. 2020 Jan 29:CIR0000000000000756. doi: 10.1161/CIR.0000000000000756.
    >> Share


  328. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e60.
    >> Share


  329. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2020;141:e59.
    >> Share

  330. MORROW DA
    The Fourth Universal Definition of Myocardial Infarction and the Emerging Importance of Myocardial Injury.
    Circulation. 2020;141:172-175.
    >> Share

  331. KALRA A, Kumbhani DJ, Hill JA
    Cardiovascular Science India Tour: Impacting Cardiovascular Disease in South Asia.
    Circulation. 2020;141:159-160.
    >> Share

  332. SREEJIT G, Abdel-Latif A, Athmanathan B, Annabathula R, et al
    Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis Following Myocardial Infarction.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.043833.
    >> Share

  333. SORIA-FLORIDO MT, Castaner O, Lassale C, Estruch R, et al
    Dysfunctional HDLs are Associated with a Greater Incidence of Acute Coronary Syndrome in a Population at High Cardiovascular Risk: A Nested-Case Control Study.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.041658.
    >> Share

  334. ZOU Z, Cini K, Dong B, Ma Y, et al
    Time Trends in Cardiovascular Disease Mortality Across the BRICS: An Age-Period-Cohort Analysis of Key Nations with Emerging Economies Using the Global Burden of Disease Study 2017.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.042864.
    >> Share

  335. KUEHN BM
    Childhood Risk Factors Contribute to Cardiovascular Events in Adults.
    Circulation. 2020;141:147-148.
    >> Share

  336. SHEN X, Tan BYQ, Sia CH, Lee JSW, et al
    Prevalence of Brugada Syndrome in a Large Population of Young Singaporean Men.
    Circulation. 2020;141:155-157.
    >> Share

  337. NEELAKANTAN N, Seah JYH, van Dam RM
    The Effect of Coconut Oil Consumption on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Clinical Trials.
    Circulation. 2020 Jan 13. doi: 10.1161/CIRCULATIONAHA.119.043052.
    >> Share

  338. GAN L, Xie D, Liu J, Lau WB, et al
    Small Extracellular Microvesicles Mediated Pathological Communications between Dysfunctional Adipocytes and Cardiomyocytes as a Novel Mechanisms Exacerbating Ischemia/Reperfusion Injury in Diabetic Mice.
    Circulation. 2020 Jan 10. doi: 10.1161/CIRCULATIONAHA.119.042640.
    >> Share

  339. KAYIKCIOGLU M, Oto A
    Control and Management of Cardiovascular Disease in Turkey.
    Circulation. 2020;141:7-9.
    >> Share

  340. RAPHAEL CE, Roger VL, Sandoval Y, Singh M, et al
    Incidence, Trends and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Circulation. 2020 Jan 6. doi: 10.1161/CIRCULATIONAHA.119.043100.
    >> Share

    December 2019
  341. BUTLER J, Packer M, Greene SJ, Fiuzat M, et al
    Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
    Circulation. 2019;140:2108-2118.
    >> Share

  342. CARSON JAS, Lichtenstein AH, Anderson CAM, Appel LJ, et al
    Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association.
    Circulation. 2019 Dec 16:CIR0000000000000743. doi: 10.1161/CIR.0000000000000743.
    >> Share

  343. GRANDI SM, Smith GN, Platt RW
    The Relative Contribution of Pregnancy Complications to Cardiovascular Risk Prediction: Are We Getting It Wrong?
    Circulation. 2019;140:1965-1967.
    >> Share

  344. WELSH P, Welsh C, Pell J, Sattar N, et al
    Response by Welsh et al to Letter Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease".
    Circulation. 2019;140:e824-e825.
    >> Share

  345. SNIDERMAN AD, Thanassoulis G, Pencina M
    Letter by Sniderman et al Regarding Article, "Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease".
    Circulation. 2019;140:e822-e823.
    >> Share

  346. SKRANES JB, Claggett BL, Myhre PL, Lyngbakken MN, et al
    Current Smoking Is Associated With Lower Concentrations of High-Sensitivity Cardiac Troponin T in Patients With Stable Coronary Artery Disease: The PEACE Trial.
    Circulation. 2019;140:2044-2046.
    >> Share

  347. GIUSTINO G, Leon MB, Stone GW
    Highlights of Transcatheter Cardiovascular Therapeutics 2019.
    Circulation. 2019;140:1943-1945.
    >> Share

  348. WAHBI K, Stalens C
    Response by Wahbi and Stalens to Letter Regarding Article, "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies".
    Circulation. 2019;140:e820-e821.
    >> Share

    November 2019
  349. BAJAJ NS, Singh A, Zhou W, Gupta A, et al
    Coronary Microvascular Dysfunction, Left Ventricular Remodeling and Clinical Outcomes in Patients with Chronic Kidney Impairment.
    Circulation. 2019 Nov 29. doi: 10.1161/CIRCULATIONAHA.119.043916.
    >> Share

  350. DE LEMOS JA, Newby LK, Mills NL
    A Proposal for Modest Revision of the Definition of Type 1 and Type 2 Myocardial Infarction.
    Circulation. 2019;140:1773-1775.
    >> Share

  351. KHERA R, Valero-Elizondo J, Das SR, Virani SS, et al
    Cost-Related Medication Nonadherence in Adults With Atherosclerotic Cardiovascular Disease in the United States, 2013 to 2017.
    Circulation. 2019 Nov 25. doi: 10.1161/CIRCULATIONAHA.119.041974.
    >> Share

  352. HUANG LUCAS C, Wu L, Yue B, Bachoo N, et al
    Abstract 10613: Symptomatic Human Immunodeficiency Virus Infected Patients Receive Less Aggressive Revascularization Management After Acute Coronary Syndrome, a 5-year Nationwide Analysis.
    Circulation. 2019;140.
    >> Share

  353. ORTEGA RF, Yancy CW, Mehran R, Batchelor W, et al
    Overcoming Lack of Diversity in Cardiovascular Clinical Trials: A New Challenge and Strategies for Success.
    Circulation. 2019;140:1690-1692.
    >> Share

  354. TAEGTMEYER H, Dasgupta P
    Chronos and Kairos in Lockstep: Thoughts on the Enduring Productivity of Cardiovascular Investigators.
    Circulation. 2019;140:1687-1689.
    >> Share

  355. PETRIE MC
    Sodium Glucose Cotransporter 2 Inhibitors: Searching for Mechanisms in the Wake of Large, Positive Cardiovascular Outcomes Trials.
    Circulation. 2019;140:1703-1705.
    >> Share

  356. AMIN AP, Spertus JA, Curtis JP, Desai N, et al
    The Evolving Landscape of Impella(R) Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention with Mechanical Circulatory Support.
    Circulation. 2019 Nov 17. doi: 10.1161/CIRCULATIONAHA.119.044007.
    >> Share

  357. ESCOBEDO MB, Aziz K, Kapadia VS, Lee HC, et al
    2019 American Heart Association Focused Update on Neonatal Resuscitation: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2019 Nov 14:CIR0000000000000729. doi: 10.1161/CIR.0000000000000729.
    >> Share

  358. PANCHAL AR, Berg KM, Cabanas JG, Kurz MC, et al
    2019 American Heart Association Focused Update on Systems of Care: Dispatcher-Assisted Cardiopulmonary Resuscitation and Cardiac Arrest Centers: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Car
    Circulation. 2019 Nov 14:CIR0000000000000733. doi: 10.1161/CIR.0000000000000733.
    >> Share

  359. PANCHAL AR, Berg KM, Hirsch KG, Kudenchuk PJ, et al
    2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support: Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation During Cardiac Arrest: An Update to the American Heart Association Guidelin
    Circulation. 2019 Nov 14:CIR0000000000000732. doi: 10.1161/CIR.0000000000000732.
    >> Share

  360. DUFF JP, Topjian AA, Berg MD, Chan M, et al
    2019 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2019 Nov 14:CIR0000000000000731. doi: 10.1161/CIR.0000000000000731.
    >> Share

  361. DUFF JP, Topjian AA, Berg MD, Chan M, et al
    2019 American Heart Association Focused Update on Pediatric Basic Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2019 Nov 14:CIR0000000000000736. doi: 10.1161/CIR.0000000000000736.
    >> Share

  362. SOAR J, Maconochie I, Wyckoff MH, Olasveengen TM, et al
    2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Educatio
    Circulation. 2019 Nov 14:CIR0000000000000734. doi: 10.1161/CIR.0000000000000734.
    >> Share

  363. RAGGI P, Bellasi A, Bushinsky D, Bover J, et al
    Slowing Progression of Cardiovascular Calcification with SNF472 in Patients on Hemodialysis: Results of a Randomized, Phase 2b Study.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044195.
    >> Share

  364. BICK AG, Pirruccello JP, Griffin GK, Gupta N, et al
    Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044362.
    >> Share

  365. RAHMAN H, Ryan M, Lumley M, Modi B, et al
    Coronary Microvascular Dysfunction Is Associated With Myocardial Ischemia and Abnormal Coronary Perfusion During Exercise.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.041595.
    >> Share

  366. LOPES RD, Leonardi S, Wojdyla DM, Vora AN, et al
    Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044584.
    >> Share

  367. DAMASK A, Steg PG, Schwartz GG, Szarek M, et al
    Patients with High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit from Alirocumab Treatment in the Odyssey Outcomes Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044434.
    >> Share

  368. SHAW LJ, Reynolds HR, Picard MH
    A Leap Forward for Ischemia-Guided Revascularization: Stress Echocardiography Predicts Angina Benefit With Percutaneous Coronary Intervention.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044026.
    >> Share

  369. AL-LAMEE RK, Shun-Shin MJ, Howard JP, Nowbar AN, et al
    Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.042918.
    >> Share

  370. CANNON CP, Perkovic V, Agarwal R, Baldassarre J, et al
    Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c <7%: Results From the CREDENCE Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044359.
    >> Share

  371. MAZER CD, Hare GMT, Connelly PW, Gilbert RE, et al
    Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044235.
    >> Share

  372. FEARON WF, De Bruyne B
    The Shifting Sands of Coronary Microvascular Dysfunction.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.043952.
    >> Share

    October 2019
  373. ROE MT, Strickler J
    Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular Disease.
    Circulation. 2019;140:1460-1462.
    >> Share

  374. MCCAW ZR, Yin G, Wei LJ
    Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies.
    Circulation. 2019;140:1366-1368.
    >> Share

  375. SATTAR N, Rawshani A, Franzen S
    Response by Sattar et al to Letters Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".
    Circulation. 2019;140:e724-e725.
    >> Share

  376. WANG J, Xu Y
    Letter by Wang and Xu Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".
    Circulation. 2019;140:e722-e723.
    >> Share

  377. AGRAWAL A
    Developing "Vital Capacity" in Cardiovascular Risk Assessment.
    Circulation. 2019;140:1291-1292.
    >> Share

  378. TROMP J, Hage C, Ouwerkerk W, Sanders-van Wijk S, et al
    Biomarker Correlates of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2019;140:1359-1361.
    >> Share

  379. WANG D, Chen T, Yang X
    Letter by Wang et al Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks".
    Circulation. 2019;140:e720-e721.
    >> Share


  380. Correction to: Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevencion con Dieta Mediterranea).
    Circulation. 2019;140:e726.
    >> Share

  381. RUEL M, Gardner TJ
    Introduction to the 2019 Cardiovascular Surgery-Themed Issue.
    Circulation. 2019;140:1231-1232.
    >> Share

  382. GODOY LC, Rao V, Farkouh ME
    Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.
    Circulation. 2019;140:1233-1235.
    >> Share

  383. CHAPMAN AR, Adamson PD, Shah ASV, Anand A, et al
    High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction.
    Circulation. 2019 Oct 7. doi: 10.1161/CIRCULATIONAHA.119.042960.
    >> Share

  384. BURROUGHS PENA MS, Mbassa RS, Slopen NB, Williams DR, et al
    Response by Burroughs Pena et al to Letter Regarding Article, "Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women".
    Circulation. 2019;140:e716-e717.
    >> Share

  385. DIAZ R, Tajer C
    Current Status and Future Strategies for Cardiovascular Disease in Argentina.
    Circulation. 2019;140:1137-1139.
    >> Share

  386. VIGNAC M, Pechmajou L, Gaye B
    Letter by Vignac et al Regarding Article, "Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women".
    Circulation. 2019;140:e715.
    >> Share

  387. TIAN R, Colucci WS, Arany Z, Bachschmid MM, et al
    Unlocking the Secrets of Mitochondria in the Cardiovascular System: Path to a Cure in Heart Failure-A Report from the 2018 National Heart, Lung, and Blood Institute Workshop
    Circulation. 2019;140:1205-1216.
    >> Share

    September 2019
  388. WATANABE H, Domei T, Morimoto T, Natsuaki M, et al
    Very Short Dual Antiplatelet Therapy after Drug-eluting Stent Implantation in Patients with High Bleeding Risk: Insight from the STOPDAPT-2 Trial.
    Circulation. 2019 Sep 27. doi: 10.1161/CIRCULATIONAHA.119.043613.
    >> Share

  389. WINDECKER S, Lopes RD, Massaro T, Jones-Burton C, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308.
    >> Share

  390. SABATE M, Alfonso F, Cequier A, Romani S, et al
    Magnesium-Based Resorbable Scaffold versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043467.
    >> Share

  391. PARK DW, Kwon O, Jang JS, Yun SC, et al
    Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.041766.
    >> Share

  392. VORA AN, Alexander JH, Wojdyla D, Aronson R, et al
    Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754.
    >> Share

  393. MARQUIS-GRAVEL G, Roe MT, Harrington RA, Munoz D, et al
    Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019;140:1115-1124.
    >> Share

  394. LEON LJ, McCarthy FP, Direk K, Gonzalez-Izquierdo A, et al
    Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study.
    Circulation. 2019;140:1050-1060.
    >> Share

  395. MARSTON NA, Giugliano RP, Im K, Silverman MG, et al
    Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
    Circulation. 2019 Sep 18. doi: 10.1161/CIRCULATIONAHA.119.041998.
    >> Share

  396. SCHRAGE B, Schneider S, Zeymer U, Thiele H, et al
    Response by Schrage et al to Letter Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".
    Circulation. 2019;140:e559-e560.
    >> Share

  397. O'NEILL WW, Ohman EM
    Letter by O'Neill and Ohman Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".
    Circulation. 2019;140:e557-e558.
    >> Share

  398. DELMAS C, Laine M, Bonello L
    Letter by Delmas et al Regarding Article, "Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis".
    Circulation. 2019;140:e555-e556.
    >> Share

  399. TERPENING CM
    A Call for More Complete Reporting of Cardiovascular Death.
    Circulation. 2019;140:887-888.
    >> Share


  400. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;140:e647-e648.
    >> Share


  401. Correction to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2019;140:e649-e650.
    >> Share

  402. CHEW DP, Lambrakis K, Blyth A, Seshadri A, et al
    A Randomized Trial of a 1-Hour Troponin T Protocol in Suspected Acute Coronary Syndromes: The Rapid Assessment of Possible ACS In the Emergency Department with High Sensitivity Troponin T (RAPID-TnT) Study.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.042891.
    >> Share

  403. ROE MT, Li QH, Bhatt DL, Bittner VA, et al
    Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
    Circulation. 2019 Sep 2. doi: 10.1161/CIRCULATIONAHA.119.042551.
    >> Share

  404. BULARGA A, Lee KK, Stewart S, Ferry AV, et al
    High-Sensitivity Troponin and The Application of Risk Stratification Thresholds in Patients with Suspected Acute Coronary Syndrome.
    Circulation. 2019 Sep 1. doi: 10.1161/CIRCULATIONAHA.119.042866.
    >> Share

    August 2019
  405. COLANTONIO LD, Muntner P
    It Is Time for Reducing Global Cardiovascular Mortality.
    Circulation. 2019;140:726-728.
    >> Share

  406. XIE J, Jiang M, Li L
    Letter by Xie et al Regarding Article, "Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications".
    Circulation. 2019;140:e513-e514.
    >> Share


  407. Correction to: Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
    Circulation. 2019;140:e543.
    >> Share


  408. Correction to: Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications.
    Circulation. 2019;140:e544.
    >> Share

  409. GRANDI SM, Platt RW
    Response by Grandi and Platt to Letter Regarding Article, "Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications".
    Circulation. 2019;140:e515-e516.
    >> Share

  410. KHANNA A, Pequeno P, Gupta S, Thavendiranathan P, et al
    Increased Risk of All Cardiovascular Disease Subtypes Among Childhood Cancer Survivors: Population-Based Matched Cohort Study.
    Circulation. 2019 Aug 26. doi: 10.1161/CIRCULATIONAHA.119.041403.
    >> Share

  411. VERMA S, Mazer CD, Yan AT, Mason T, et al
    Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375.
    >> Share

  412. OUCHI Y, Sasaki J, Arai H, Yokote K, et al
    Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.118.039415.
    >> Share

  413. ZHANG S, Zhuang X, Liao X
    Letter by Zhang et al Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study".
    Circulation. 2019;140:e329-e330.
    >> Share

  414. AGHA G, Mendelson MM, Ward-Caviness CK, Joehanes R, et al
    Blood Leukocyte DNA Methylation Predicts Risk of Future Myocardial Infarction and Coronary Heart Disease.
    Circulation. 2019;140:645-657.
    >> Share

  415. ARORA S, Rosamond WD, Caughey MC
    Response by Arora et al to Letter Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study".
    Circulation. 2019;140:e331-e332.
    >> Share

  416. SHAKIBA M, Mansournia MA
    Letter by Shakiba and Mansournia Regarding Article, "Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015".
    Circulation. 2019;140:e325-e326.
    >> Share

  417. ZEKI AL HAZZOURI A, Elfassy T, Glymour MM
    Response by Zeki Al Hazzouri et al to Letter Regarding Article, "Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015".
    Circulation. 2019;140:e327-e328.
    >> Share

  418. LARSSON SC, Markus HS
    Genetic Liability to Insomnia and Cardiovascular Disease Risk.
    Circulation. 2019 Aug 19. doi: 10.1161/CIRCULATIONAHA.119.041830.
    >> Share

  419. DEFILIPPIS AP, Chapman AR, Mills NL, de Lemos JA, et al
    Assessment and Treatment of Patients with Type 2 Myocardial Infarction and Acute Non-Ischemic Myocardial Injury.
    Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.040631.
    >> Share

  420. THAN MP, Pickering JW, Sandoval Y, Shah ASV, et al
    Machine Learning to Predict the Likelihood of Acute Myocardial Infarction.
    Circulation. 2019 Aug 16. doi: 10.1161/CIRCULATIONAHA.119.041980.
    >> Share

  421. WANG W
    Letter by Wang Regarding Article, "Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation".
    Circulation. 2019;140:e290-e291.
    >> Share

  422. CLELAND JGF, Pellicori P
    Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure.
    Circulation. 2019;140:538-541.
    >> Share

  423. MAULER M, Hilgendorf I, Duerschmied D
    Response by Mauler et al to Letter Regarding Article, "Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation".
    Circulation. 2019;140:e292-e293.
    >> Share

  424. AENGEVAEREN VL, Hopman MTE, Thompson PD, Bakker EA, et al
    Exercise-Induced Cardiac Troponin I Increase and Incident Mortality and Cardiovascular Events.
    Circulation. 2019 Aug 12. doi: 10.1161/CIRCULATIONAHA.119.041627.
    >> Share

  425. FOO RS, Anene-Nzelu CG, Rosa-Garrido M, Vondriska TM, et al
    Dissecting Chromatin Architecture for Novel Cardiovascular Disease Targets.
    Circulation. 2019;140:446-448.
    >> Share

  426. PACKER M
    Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
    Circulation. 2019;140:443-445.
    >> Share

    July 2019
  427. FAN Q, Mao H, Angelini A, Coarfa C, et al
    Depletion of Endothelial Prolyl Hydroxylase Domain Protein 2 and 3 Promotes Cardiomyocyte Proliferation and Prevents Ventricular Failure Induced by Myocardial Infarction.
    Circulation. 2019;140:440-442.
    >> Share

  428. FAN Q, Zhang R, Yan X
    Response by Fan et al to Letter Regarding Article, "Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration".
    Circulation. 2019;140:e179-e180.
    >> Share

  429. TANDON A, de Ferranti SD
    Wearable Biosensors in Pediatric Cardiovascular Disease.
    Circulation. 2019;140:350-352.
    >> Share

  430. LI Y, Shen Z, Yu XY
    Letter by Li et al Regarding Article, "Dectin-1 Contributes to Myocardial Ischemia/Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration".
    Circulation. 2019;140:e177-e178.
    >> Share

  431. BRILAKIS ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, et al
    Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;140:420-433.
    >> Share

  432. BICK AG, Akwo E, Robinson-Cohen C, Lee K, et al
    Association of APOL1 Risk Alleles with Cardiovascular Disease in African Americans in the Million Veteran Program.
    Circulation. 2019 Jul 24. doi: 10.1161/CIRCULATIONAHA.118.036589.
    >> Share


  433. Correction to: Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019;140:e171.
    >> Share

  434. HE Z, Ding R, Liang C
    Letter by He et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e156-e157.
    >> Share

  435. ZHU J, Peng X, Zheng Z
    Letter by Zhu et al Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e152-e153.
    >> Share

  436. FUERNAU G, Thiele H
    Response by Fuernau and Thiele to Letters Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e158-e159.
    >> Share


  437. Correction to: Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction.
    Circulation. 2019;140:e162.
    >> Share

  438. BENGUEDDACHE S, Bendjelid K
    Letter by Bengueddache and Bendjelid Regarding Article, "Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction: Randomized SHOCK-COOL Trial".
    Circulation. 2019;140:e154-e155.
    >> Share

  439. KUEHN BM
    Community-Based Cardiovascular Interventions Gain Steam.
    Circulation. 2019;140:262-263.
    >> Share

  440. MAHAFFEY KW, Jardine MJ, Bompoint S, Cannon CP, et al
    Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial.
    Circulation. 2019 Jul 11. doi: 10.1161/CIRCULATIONAHA.119.042007.
    >> Share

  441. WESTRA J, Andersen BK, Holm NR
    Letter by Westra et al Regarding Article, "Accuracy of Fractional Flow Reserve Derived From Coronary Angiography".
    Circulation. 2019;140:e94-e95.
    >> Share

  442. FEARON WF, Kornowski R, De Bruyne B
    Response by Fearon et al to Letter Regarding Article, "Accuracy of Fractional Flow Reserve Derived From Coronary Angiography".
    Circulation. 2019;140:e96-e97.
    >> Share

  443. BAYS HE
    Alirocumab, Decreased Mortality, Nominal Significance, P Values, Bayesian Statistics, and the Duplicity of Multiplicity.
    Circulation. 2019;140:113-116.
    >> Share

  444. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    >> Share

  445. BUENO H, Perez-Gomez B
    Global Rounds: Cardiovascular Health, Disease, and Care in Spain.
    Circulation. 2019;140:13-15.
    >> Share

  446. TALEB I, Koliopoulou AG, Tandar A, McKellar SH, et al
    Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept.
    Circulation. 2019;140:98-100.
    >> Share

    June 2019
  447. WELSH C, Celis-Morales CA, Brown R, Mackay DF, et al
    Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank.
    Circulation. 2019 Jun 20. doi: 10.1161/CIRCULATIONAHA.119.041149.
    >> Share

  448. KHALID N, Shlofmitz E, Waksman R
    Letter by Khalid et al Regarding Article, "Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction: A Pilot Study Using the Impella CP".
    Circulation. 2019;139:e1040-e1041.
    >> Share


  449. Correction to: Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.
    Circulation. 2019;139:e1188.
    >> Share

  450. DI VECE D, Citro R, Templin C
    Response by Di Vece et al to Letter Regarding Article, "Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry".
    Circulation. 2019;139:e1044-e1045.
    >> Share

  451. Y-HASSAN S
    Letter by Y-Hassan Regarding Article, "Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome: Results From the International Takotsubo Registry".
    Circulation. 2019;139:e1042-e1043.
    >> Share

  452. WANG D, Yang X, Zhong H
    Letter by Wang et al Regarding Article, "Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".
    Circulation. 2019;139:e1033-e1034.
    >> Share

  453. BANSAL SS, Ismahil MA, Goel M, Zhou G, et al
    Response by Bansal et al to Letter Regarding Article, "Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy".
    Circulation. 2019;139:e1035-e1036.
    >> Share

  454. BIKDELI B, Welsh JW, Akram Y, Punnanithinont N, et al
    Non-Inferiority Designed Cardiovascular Trials in Highest-Impact Journals: Main Findings, Methodological Quality and Time Trends.
    Circulation. 2019 Jun 10. doi: 10.1161/CIRCULATIONAHA.119.040214.
    >> Share

  455. ARNOLD SV, de Lemos JA, Rosenson RS, Ballantyne CM, et al
    Use of Guideline-Recommended Risk-Reduction Strategies Among Patients with Diabetes and Atherosclerotic Cardiovascular Disease: Insights from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOUL
    Circulation. 2019 Jun 7. doi: 10.1161/CIRCULATIONAHA.119.041730.
    >> Share

  456. ARAVANI D, Morris GE, Jones PD, Tattersall HK, et al
    HHIPL1, a Gene at the 14q32 Coronary Artery Disease Locus, Positively Regulates Hedgehog Signaling and Promotes Atherosclerosis.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.041059.
    >> Share

  457. BRANCH KR, Probstfield JL, Eikelboom JW, Bosch J, et al
    Rivaroxaban With or Without Aspirin in Patients with Heart Failure and Chronic Coronary or Peripheral Artery Disease: The COMPASS Trial.
    Circulation. 2019 Jun 5. doi: 10.1161/CIRCULATIONAHA.119.039609.
    >> Share

  458. OLDE RIKKERT MGM, Fernandes M
    Letter by Olde Rikkert and Fernandes Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1021-e1022.
    >> Share

  459. BRESS AP, Muntner P, Moran AE
    Response by Bress et al to Letters Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1023-e1024.
    >> Share

  460. RUEDA-OCHOA OL, Rizopoulos D, Kavousi M
    Letter by Rueda-Ochoa et al Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".
    Circulation. 2019;139:e1019-e1020.
    >> Share

  461. FEINSTEIN MJ, Hsue PY, Benjamin LA, Bloomfield GS, et al
    Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Jun 3:CIR0000000000000695. doi: 10.1161/CIR.0000000000000695.
    >> Share

    May 2019
  462. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Response by Mann et al to Letter Regarding Article, "Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial".
    Circulation. 2019;139:e1017-e1018.
    >> Share

  463. XIE J, Jiang M, Li L
    Letter by Xie et al Regarding Article, "Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial".
    Circulation. 2019;139:e1015-e1016.
    >> Share

  464. KONSTAM MA, Konstam AD
    Gun Violence and Cardiovascular Health.
    Circulation. 2019;139:2499-2501.
    >> Share

  465. STEG PG, Szarek M, Bhatt DL, Bittner VA, et al
    Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038840.
    >> Share

  466. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
    Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk.
    Circulation. 2019 May 22. doi: 10.1161/CIRCULATIONAHA.119.040167.
    >> Share

  467. KARAM N, Marijon E, Jouven X
    Letter by Karam et al Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry".
    Circulation. 2019;139:e994-e995.
    >> Share

  468. DEFILIPPIS EM, Singh A, Bhatt DL, Blankstein R, et al
    Response by DeFilippis et al to Letter Regarding Article, "Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction: Partners YOUNG-MI Registry".
    Circulation. 2019;139:e996.
    >> Share

  469. KUEHN BM
    Sleep Duration Linked to Cardiovascular Disease.
    Circulation. 2019;139:2483-2484.
    >> Share

  470. SANDERS TAB
    Omega-6 Fatty Acids and Cardiovascular Disease.
    Circulation. 2019;139:2437-2439.
    >> Share

  471. NYSTROM T, Sartipy U, Contardi A, Lind M, et al
    Glycated Hemoglobin A1c Levels in Type 1 Diabetes Mellitus and Outcomes After Myocardial Infarction.
    Circulation. 2019;139:2380-2382.
    >> Share

  472. BONELLO L, Laine M, Lemesle G
    Letter by Bonello et al Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".
    Circulation. 2019;139:e959-e960.
    >> Share

  473. KOFOED KF, Kelbaek H, Engstrom T, Kober LV, et al
    Response by Kofoed et al to Letter Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".
    Circulation. 2019;139:e961-e962.
    >> Share

  474. THOMAS RJ, Beatty AL, Beckie TM, Brewer LC, et al
    Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.
    Circulation. 2019 May 13:CIR0000000000000663. doi: 10.1161/CIR.0000000000000663.
    >> Share

  475. CAPPOLA AR, Desai AS, Medici M, Cooper LS, et al
    Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment.
    Circulation. 2019 May 13. doi: 10.1161/CIRCULATIONAHA.118.036859.
    >> Share

  476. AGIRBASLI M, Aksoy A
    Letter by Agirbasli and Aksoy Regarding Article, "Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population".
    Circulation. 2019;139:e911-e912.
    >> Share

  477. DOOSTI-IRANI A, Mansournia MA, Collins G
    Letter by Doosti-Irani et al Regarding Article, "Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population".
    Circulation. 2019;139:e909-e910.
    >> Share

    April 2019
  478. RAVNSKOV U, Okuyama H, Sultan S
    Letter by Ravnskov et al Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longit
    Circulation. 2019;139:2188-2189.
    >> Share

  479. ABDULLAH SM, Defina LF, Leonard D, Khera A, et al
    Response by Abdullah et al to Letters Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper
    Circulation. 2019;139:2192-2193.
    >> Share

  480. KE C, Shen Y
    Letter by Ke and Shen Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudi
    Circulation. 2019;139:2190-2191.
    >> Share

  481. GURBEL PA, Fox KAA, Tantry US, Ten Cate H, et al
    Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease.
    Circulation. 2019;139:2170-2185.
    >> Share

  482. BANGALORE S
    Response by Bangalore to Letter Regarding Article, "Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials".
    Circulation. 2019;139:2083-2084.
    >> Share

  483. ROMAGUERA R, Gomez-Lara J, Gomez-Hospital JA
    Letter by Romaguera et al Regarding Article, "Newer Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: Meta-Analysis of Randomized Trials".
    Circulation. 2019;139:2081-2082.
    >> Share

  484. SANO M, Goto S
    Possible Mechanism of Hematocrit Elevation by Sodium Glucose Cotransporter 2 Inhibitors and Associated Beneficial Renal and Cardiovascular Effects.
    Circulation. 2019;139:1985-1987.
    >> Share

  485. KEY TJ, Appleby PN, Bradbury KE, Sweeting M, et al
    Consumption of Meat, Fish, Dairy Products, Eggs and Risk of Ischemic Heart Disease: A Prospective Study of 7198 Incident Cases Among 409,885 Participants in the Pan-European EPIC Cohort.
    Circulation. 2019 Apr 22. doi: 10.1161/CIRCULATIONAHA.118.038813.
    >> Share

  486. PUSKAS JD, Gaudino M, Taggart DP
    Experience Is Crucial in Off-Pump Coronary Artery Bypass Grafting.
    Circulation. 2019;139:1872-1875.
    >> Share

  487. PAHIGIANNIS K, Thompson-Paul AM, Barfield W, Ochiai E, et al
    Progress Toward Improved Cardiovascular Health in the United States.
    Circulation. 2019;139:1957-1973.
    >> Share

  488. LARSEN TR, Padala SK, Ellenbogen KA
    Resolution of Bundle Branch Block.
    Circulation. 2019;139:1974-1976.
    >> Share

  489. WRIGHT AK, Kontopantelis E, Emsley R, Buchan IE, et al
    Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities.
    Circulation. 2019 Apr 15. doi: 10.1161/CIRCULATIONAHA.118.039100.
    >> Share

  490. MARKLUND M, Wu JHY, Imamura F, Del Gobbo LC, et al
    Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies.
    Circulation. 2019 Apr 11. doi: 10.1161/CIRCULATIONAHA.118.038908.
    >> Share

  491. GUASCH-FERRE M, Satija A, Blondin SA, Janiszewski M, et al
    Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors.
    Circulation. 2019;139:1828-1845.
    >> Share

  492. GILCHRIST SC, Barac A, Ades PA, Alfano CM, et al
    Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Apr 8:CIR0000000000000679. doi: 10.1161/CIR.0000000000000679.
    >> Share

  493. SATTAR N, Rawshani A, Franzen S, Rawshani A, et al
    Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks Findings From the Swedish National Diabetes Registry.
    Circulation. 2019 Apr 8. doi: 10.1161/CIRCULATIONAHA.118.037885.
    >> Share

  494. HUANG S, Li X, Zheng H, Si X, et al
    Loss of Super-Enhancer-Regulated CircRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice.
    Circulation. 2019 Apr 5. doi: 10.1161/CIRCULATIONAHA.118.038361.
    >> Share

  495. ERLINGE D
    Cangrelor for ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2019;139:1671-1673.
    >> Share

  496. MILLS NL, Omland T
    Cardiac Troponin to Guide the Use of Noninvasive Testing in Patients Ruled Out for Myocardial Infarction.
    Circulation. 2019;139:1655-1657.
    >> Share

  497. LOW WANG CC, Everett BM, Burman KD, Wilson PWF, et al
    Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?
    Circulation. 2019;139:1741-1743.
    >> Share


  498. Correction to: High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD).
    Circulation. 2019;139:e836.
    >> Share

  499. BRILAKIS ES, Mashayekhi K, Burke MN
    How DECISION-CTO Can Help Guide the Decision to Perform Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circulation. 2019;139:1684-1687.
    >> Share

  500. SLIWA K, Ntusi N
    Battling Cardiovascular Diseases in a Perfect Storm.
    Circulation. 2019;139:1658-1660.
    >> Share

  501. SANDOVAL Y, Smith SW, Sexter A, Gunsolus IL, et al
    Clinical Features and Outcomes of Emergency Department Patients With High-Sensitivity Cardiac Troponin I Concentrations Within Sex-Specific Reference Intervals.
    Circulation. 2019;139:1753-1755.
    >> Share

  502. KOMATSU Y, Hocini M, Nogami A, Maury P, et al
    Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study.
    Circulation. 2019 Apr 1. doi: 10.1161/CIRCULATIONAHA.118.037997.
    >> Share

    March 2019
  503. TAMIS-HOLLAND JE, Jneid H, Reynolds HR, Agewall S, et al
    Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Mar 27:CIR0000000000000670. doi: 10.1161/CIR.0000000000000670.
    >> Share

  504. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
    Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
    Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
    >> Share

  505. PLAYAN-ESCRIBANO J, Martinez-Losas P, Cobos-Gil MA
    Electrocardiographic Changes After Angioplasty of the Left Anterior Descending Coronary Artery.
    Circulation. 2019;139:1550-1553.
    >> Share

  506. YANNOPOULOS D, Bartos JA, Aufderheide TP, Callaway CW, et al
    The Evolving Role of the Cardiac Catheterization Laboratory in the Management of Patients With Out-of-Hospital Cardiac Arrest: A Scientific Statement From the American Heart Association.
    Circulation. 2019;139:e530-e552.
    >> Share

  507. ZLATANOVA I, Pinto C, Bonnin P, Mathieu JRR, et al
    Iron Regulator Hepcidin Impairs Macrophage-Dependent Cardiac Repair After Injury.
    Circulation. 2019;139:1530-1547.
    >> Share

  508. FURTADO RHM, Bonaca MP, Raz I, Zelniker TA, et al
    Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039996.
    >> Share

  509. BONSU J, Charles L, Guha A, Awan F, et al
    Representation of Patients with Cardiovascular Disease in Pivotal Cancer Clinical Trials.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.118.039180.
    >> Share

  510. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17:CIR0000000000000678. doi: 10.1161/CIR.0000000000000678.
    >> Share

  511. ARNETT DK, Blumenthal RS, Albert MA, Buroker AB, et al
    2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary.
    Circulation. 2019 Mar 17:CIR0000000000000677. doi: 10.1161/CIR.0000000000000677.
    >> Share

  512. BITTNER VA
    The New 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040625.
    >> Share

  513. PICKERING JW
    The Need to Improve Derivation and Description of Algorithms to Rule-Out Patients With Possible Myocardial Infarction.
    Circulation. 2019;139:1351-1353.
    >> Share

  514. LONG M, Ye Z, Li L
    Letter by Long et al Regarding Article, "Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease".
    Circulation. 2019;139:1467-1468.
    >> Share

  515. KUEHN BM
    Large Trial Finds Yoga Boosts Quality of Life and Return to Activity and Adds to Emerging Evidence for Rehabilitation Alternatives.
    Circulation. 2019;139:1451-1453.
    >> Share

  516. BHATNAGAR A, Maziak W, Eissenberg T, Ward KD, et al
    Water Pipe (Hookah) Smoking and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Mar 8:CIR0000000000000671. doi: 10.1161/CIR.0000000000000671.
    >> Share

  517. KUWABARA M
    Letter by Kuwabara Regarding Article, "Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study".
    Circulation. 2019;139:1348-1349.
    >> Share

  518. DORING Y, van der Vorst EPC, Duchene J, Jansen Y, et al
    CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease.
    Circulation. 2019;139:1338-1340.
    >> Share

  519. POULIDAKIS E, Spaulding C
    Cardiac Assist Devices in Cardiogenic Shock.
    Circulation. 2019;139:1259-1261.
    >> Share

    February 2019
  520. BURROUGHS-PENA MS, Mbassa RS, Slopen NB, Williams DR, et al
    Cumulative Psychosocial Stress and Ideal Cardiovascular Health in Older Women: Data by Race/Ethnicity.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.033915.
    >> Share

  521. SAHA P, Potiny P, Rigdon J, Morello M, et al
    Substantial Cardiovascular Morbidity in Adults with Lower-Complexity Congenital Heart Disease.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.037064.
    >> Share

  522. LEE SW, Lee PH, Ahn JM, Park DW, et al
    Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.031313.
    >> Share

  523. MEHTA A, Mandawat A
    Letter by Mehta and Mandawat Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".
    Circulation. 2019;139:1243-1244.
    >> Share


  524. Correction to: Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:e55.
    >> Share

  525. NAFEE T, Gibson CM, Yee MK, Kerneis M, et al
    Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
    Circulation. 2019;139:1234-1236.
    >> Share

  526. SIMES J, Kirby A, Tonkin A
    Response by Simes et al to Letter Regarding Article, "D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease".
    Circulation. 2019;139:1245-1246.
    >> Share

  527. DIVANJI P, Deo R, Harris I
    Coronary Arteries and the Cell Count.
    Circulation. 2019;139:1228-1233.
    >> Share

  528. RAWSHANI A, Rawshani A, Sattar N, Franzen S, et al
    Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes.
    Circulation. 2019 Feb 25. doi: 10.1161/CIRCULATIONAHA.118.037454.
    >> Share

  529. DE FERRANTI SD, Steinberger J, Ameduri R, Baker A, et al
    Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Feb 25:CIR0000000000000618. doi: 10.1161/CIR.0000000000000618.
    >> Share

  530. ZELNIKER TA, Wiviott SD, Raz I, Im K, et al
    Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of
    Circulation. 2019 Feb 21. doi: 10.1161/CIRCULATIONAHA.118.038868.
    >> Share

  531. VACCARINO V
    Myocardial Infarction in Young Women.
    Circulation. 2019;139:1057-1059.
    >> Share

  532. PETERS SAE, Muntner P, Woodward M
    Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016.
    Circulation. 2019;139:1025-1035.
    >> Share

  533. BARISH R, Lynce F, Unger K, Barac A, et al
    Management of Cardiovascular Disease in Women With Breast Cancer.
    Circulation. 2019;139:1110-1120.
    >> Share

  534. BUI QM, Daniels LB
    A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women.
    Circulation. 2019;139:1094-1101.
    >> Share

  535. KALINOWSKI J, Taylor JY, Spruill TM
    Why Are Young Black Women at High Risk for Cardiovascular Disease?
    Circulation. 2019;139:1003-1004.
    >> Share

  536. OUYANG D, Harrington RA, Rodriguez F
    Association Between Female Corresponding Authors and Female Co-Authors in Top Contemporary Cardiovascular Medicine Journals.
    Circulation. 2019;139:1127-1129.
    >> Share

  537. HAN JK, Yano EM, Watson KE, Ebrahimi R, et al
    Cardiovascular Care in Women Veterans.
    Circulation. 2019;139:1102-1109.
    >> Share

  538. GRANDI SM, Filion KB, Yoon S, Ayele HT, et al
    Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications.
    Circulation. 2019;139:1069-1079.
    >> Share

  539. BELLETTIERE J, LaMonte MJ, Evenson KR, Rillamas-Sun E, et al
    Sedentary behavior and cardiovascular disease in older women: The Objective Physical Activity and Cardiovascular Health (OPACH) Study.
    Circulation. 2019;139:1036-1046.
    >> Share

  540. HOCHMAN JS, Rutherford JD
    Clinical Studies in Myocardial Revascularization.
    Circulation. 2019;139:1007-1011.
    >> Share

  541. HAUKILAHTI MAE, Holmstrom L, Vahatalo J, Kentta T, et al
    Sudden Cardiac Death in Women.
    Circulation. 2019;139:1012-1021.
    >> Share

  542. NOTA NM, Wiepjes CM, de Blok CJM, Gooren LJG, et al
    The Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy: Results from a Large Cohort Study.
    Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.038584.
    >> Share

  543. BENSCHOP L, Schalekamp-Timmermans S, Broere-Brown ZA, Roeters van Lennep JE, et al
    Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy.
    Circulation. 2019 Feb 14. doi: 10.1161/CIRCULATIONAHA.118.036632.
    >> Share

  544. RABINOVICH-NIKITIN I, Lieberman B, Martino TA, Kirshenbaum LA, et al
    Circadian-Regulated Cell Death in Cardiovascular Diseases.
    Circulation. 2019;139:965-980.
    >> Share

  545. MORROW DA, Wiviott SD
    Classification of Deaths in Cardiovascular Outcomes Trials.
    Circulation. 2019;139:874-876.
    >> Share

  546. SPATZ ES, Herrin J
    Cardiovascular Outcomes in the Wake of Financial Uncertainty.
    Circulation. 2019;139:860-862.
    >> Share

  547. MORDI IR, Pearson ER, Palmer CNA, Doney ASF, et al
    Differential Association of Genetic Risk of Coronary Artery Disease With Development of Heart Failure With Reduced Versus Preserved Ejection Fraction.
    Circulation. 2019;139:986-988.
    >> Share

  548. LEE JM, Choi KH, Park J, Hwang D, et al
    Physiological and Clinical Assessment of Resting Physiological Indexes.
    Circulation. 2019;139:889-900.
    >> Share

  549. DIEGELER A, Borgermann J, Kappert U, Hilker M, et al
    Five-Year Outcome after Off-Pump or On-Pump Coronary Artery Bypass Grafting in Elderly Patients.
    Circulation. 2019 Feb 8. doi: 10.1161/CIRCULATIONAHA.118.035857.
    >> Share

  550. LI DJ, Chen XP, Zhang XB
    Letter by Li et al Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:839-840.
    >> Share

  551. BRINTON TJ, Ali ZA, Hill JM, Meredith IT, et al
    Feasibility of Shockwave Coronary Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses.
    Circulation. 2019;139:834-836.
    >> Share

  552. SU Q, Li Q
    Letter by Su and Li Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:837-838.
    >> Share

  553. PETRIE JR, Sattar N
    Excess Cardiovascular Risk in Type 1 Diabetes Mellitus.
    Circulation. 2019;139:744-747.
    >> Share

  554. UDDIN SMI, Dardari Z, Blaha MJ
    Response by Uddin et al to Letters Regarding Article, "Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis".
    Circulation. 2019;139:841-842.
    >> Share

    January 2019
  555. LIM CC, Hayes RB, Ahn J, Shao Y, et al
    Mediterranean Diet and the Association Between Air Pollution and Cardiovascular Disease Mortality Risk.
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035742.
    >> Share

  556. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
    Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients with Coronary Heart Disease.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.038036.
    >> Share

  557. WANG Y, Dembowsky K, Chevalier E, Stuve P, et al
    C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.036053.
    >> Share

  558. MCMILLAN A, Hazen SL
    Gut Microbiota Involvement in Ventricular Remodeling Post-Myocardial Infarction.
    Circulation. 2019;139:660-662.
    >> Share

  559. HAKEEM A, Uretsky BF
    Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes.
    Circulation. 2019;139:694-706.
    >> Share

  560. TANG TWH, Chen HC, Chen CY, Yen CYT, et al
    Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.
    Circulation. 2019;139:647-659.
    >> Share

  561. MCCLELLAN M, Brown N, Califf RM, Warner JJ, et al
    Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association.
    Circulation. 2019 Jan 24:CIR0000000000000652. doi: 10.1161/CIR.0000000000000652.
    >> Share

  562. PARE G, Caku A, McQueen M, Anand SS, et al
    Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.034311.
    >> Share

  563. SANDOVAL Y, Jaffe AS, Apple FS
    Letter by Sandoval et al Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction".
    Circulation. 2019;139:562-563.
    >> Share

  564. MCCORD J, Newby LK, deFilippi CR
    Response by McCord et al to Letter Regarding Article, "Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Inf
    Circulation. 2019;139:564-565.
    >> Share

  565. HAO Y, Liu J, Liu J, Yang N, et al
    Sex Differences in In-hospital Management and Outcomes of Patients with Acute Coronary Syndrome: Findings from the Improving Care for Cardiovascular Disease in China (CCC) Project.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.037655.
    >> Share

  566. SHARMA M, Hart RG, Connolly SJ, Bosch J, et al
    Stroke Outcomes in the Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) Trial.
    Circulation. 2019 Jan 22. doi: 10.1161/CIRCULATIONAHA.118.035864.
    >> Share

  567. ATIENZA F, Marquez MF, Sanchez-Quintana D
    Letter by Atienza et al Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
    Circulation. 2019;139:566-567.
    >> Share

  568. THIENE G, Saffitz JE
    Response by Thiene and Saffitz to Letter Regarding Article, "Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now".
    Circulation. 2019;139:568-569.
    >> Share

  569. MATHIYALAGAN P, Adamiak M, Mayourian J, Sassi Y, et al
    FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.
    Circulation. 2019;139:518-532.
    >> Share


  570. Correction to: Waiting for Godot: Engaging in Discussions About Depression Care in Patients With Acute Myocardial Infarction While Waiting for a Definitive Trial That Never Appears.
    Circulation. 2019;139:e7.
    >> Share


  571. Correction to: Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2019;139:e9.
    >> Share

  572. FIGTREE GA, Radholm K, Neal B
    Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:418-419.
    >> Share

  573. KOH KK
    Letter by Koh Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".
    Circulation. 2019;139:416-417.
    >> Share

  574. PATEL MR
    Percutaneous Support Devices for Percutaneous Coronary Intervention.
    Circulation. 2019;139:347-350.
    >> Share

  575. DI VECE D, Citro R, Cammann VL, Kato K, et al
    Outcomes Associated With Cardiogenic Shock in Takotsubo Syndrome.
    Circulation. 2019;139:413-415.
    >> Share

  576. FRANCHI F, Rollini F, Rivas A, Wali M, et al
    Platelet Inhibition with Cangrelor and Crushed Ticagrelor in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of the CANTIC Study.
    Circulation. 2019 Jan 11. doi: 10.1161/CIRCULATIONAHA.118.038317.
    >> Share


  577. Correction to: Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events.
    Circulation. 2019;139:e2.
    >> Share

  578. NASSIF ME, Kosiborod M
    Response by Nassif and Kosiborod to Letter Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".
    Circulation. 2019;139:305-306.
    >> Share

  579. POTIER L, Roussel R
    Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".
    Circulation. 2019;139:303-304.
    >> Share

  580. BANSAL SS, Ismahil MA, Goel M, Zhou G, et al
    Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
    Circulation. 2019;139:206-221.
    >> Share

  581. ELFASSY T, Swift SL, Glymour MM, Calonico S, et al
    Associations of Income Volatility With Incident Cardiovascular Disease and All-Cause Mortality in a US Cohort: 1990 to 2015.
    Circulation. 2019 Jan 7. doi: 10.1161/CIRCULATIONAHA.118.035521.
    >> Share

  582. VANHAVERBEKE M, Bogaerts K, Sinnaeve PR, Janssens L, et al
    Prevention of Cardiogenic Shock After Acute Myocardial Infarction.
    Circulation. 2019;139:137-139.
    >> Share

  583. OEMRAWSINGH RM, Akkerhuis KM, de Mulder M, Umans VA, et al
    High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.
    Circulation. 2019;139:134-136.
    >> Share

  584. PRABHAKARAN D, Jaacks LM
    Reflections From India on Scaling Up Risk Factor Control for Cardiovascular Diseases to Reach 1 Billion Adults.
    Circulation. 2019;139:4-6.
    >> Share

  585. BRESS AP, Colantonio LD, Cooper RS, Kramer H, et al
    Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.
    Circulation. 2019;139:24-36.
    >> Share

  586. ROZEMEIJER R, Stein M, Voskuil M, van den Bor R, et al
    Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent.
    Circulation. 2019;139:67-77.
    >> Share

    December 2018
  587. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    >> Share

  588. FRIEDMAN DJ, Al-Khatib SM
    Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2972-2973.
    >> Share

  589. BROUWER TF, Burke MC, Knops RE
    Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2970-2971.
    >> Share

  590. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    >> Share

  591. DEFILIPPIS EM, Singh A, Gupta A, Ayuba G, et al
    Long-Term Outcomes After Out-of-Hospital Cardiac Arrest in Young Patients With Myocardial Infarction.
    Circulation. 2018;138:2855-2857.
    >> Share

  592. KOFOED KF, Kelbaek H, Hansen PR, Torp-Pedersen C, et al
    Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Circulation. 2018;138:2741-2750.
    >> Share

  593. JOLLY SS, Mehta SR
    Timing of Intervention in Non-ST Elevation Acute Coronary Syndromes.
    Circulation. 2018;138:2751-2753.
    >> Share


  594. Correction to: Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial.
    Circulation. 2018;138:e750.
    >> Share

  595. JERNBERG T, Lindahl B, Alfredsson J, Berglund E, et al
    Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
    Circulation. 2018;138:2754-2762.
    >> Share

  596. PENCINA MJ, Navar AM, Wojdyla D, Sanchez RJ, et al
    Quantifying Importance of Major Risk Factors for Coronary Heart Disease.
    Circulation. 2018 Dec 7. doi: 10.1161/CIRCULATIONAHA.117.031855.
    >> Share

  597. FITCHETT D, Inzucchi SE, Cannon CP, McGuire DK, et al
    Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
    Circulation. 2018 Dec 6. doi: 10.1161/CIRCULATIONAHA.118.037778.
    >> Share

  598. SCHRAGE B, Ibrahim K, Loehn T, Werner N, et al
    Impella Support for Acute Myocardial Infarction complicated by Cardiogenic Shock: A Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.036614.
    >> Share

  599. TSUTSUMI K, Tsukahara K
    Is The Diagnosis ST-Segment Elevation or Non-ST-Segment Elevation Myocardial Infarction?
    Circulation. 2018;138:2715-2717.
    >> Share

  600. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2724-2725.
    >> Share

  601. KIMURA T, Iimuro S, Taguchi I, Iwata H, et al
    Response by Kimura et al to Letters Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2728-2729.
    >> Share

  602. GONG L, Cao Y, Yang G
    Letter by Gong et al Regarding Article, "High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial".
    Circulation. 2018;138:2726-2727.
    >> Share

  603. DUFF JP, Topjian A, Berg MD, Chan M, et al
    2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2018;138:e731-e739.
    >> Share

  604. SOAR J, Donnino MW, Maconochie I, Aickin R, et al
    2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
    Circulation. 2018;138:e714-e730.
    >> Share

  605. PANCHAL AR, Berg KM, Kudenchuk PJ, Del Rios M, et al
    2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation an
    Circulation. 2018;138:e740-e749.
    >> Share

  606. KIM MK, Han K, Park YM, Kwon HS, et al
    Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population.
    Circulation. 2018;138:2627-2637.
    >> Share

  607. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    >> Share

    November 2018
  608. O'DONOGHUE ML, Fazio S, Giugliano RP, Stroes ESG, et al
    Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial.
    Circulation. 2018 Nov 30. doi: 10.1161/CIRCULATIONAHA.118.037184.
    >> Share

  609. MENTZ RJ, Thompson VP, Aguilar D, Choi J, et al
    Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
    Circulation. 2018;138:2576-2578.
    >> Share

  610. CAO DJ
    Macrophages in Cardiovascular Homeostasis and Disease.
    Circulation. 2018;138:2452-2455.
    >> Share

  611. AMEGAH AK
    Tackling the Growing Burden of Cardiovascular Diseases in Sub-Saharan Africa.
    Circulation. 2018;138:2449-2451.
    >> Share

  612. SOUSA GR, Pober D, Galderisi A, Lv H, et al
    Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus: A DCCT/EDIC Cohort-Based Study.
    Circulation. 2018 Nov 26. doi: 10.1161/CIRCULATIONAHA.118.036068.
    >> Share

  613. BUDOFF MJ, Lutz SM, Kinney GL, Young KA, et al
    Coronary Artery Calcium on Noncontrast Thoracic Computerized Tomography Scans and All-Cause Mortality.
    Circulation. 2018;138:2437-2438.
    >> Share

  614. ABDULLAH SM, Defina LF, Leonard D, Barlow CE, et al
    Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018;138:2315-2325.
    >> Share

  615. GUNADASA-ROHLING M, Masters M, Maguire ML, Smart SC, et al
    Magnetic Resonance Imaging of the Regenerating Neonatal Mouse Heart.
    Circulation. 2018;138:2439-2441.
    >> Share

  616. JHA AK
    Letter by Jha Regarding Article, "High-Target Versus Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients: A Randomized Controlled Trial".
    Circulation. 2018;138:2443-2444.
    >> Share

  617. WADE KH, Chiesa ST, Hughes AD, Chaturvedi N, et al
    Assessing the causal role of body mass index on cardiovascular health in young adults: Mendelian randomization and recall-by-genotype analyses.
    Circulation. 2018;138:2187-2201.
    >> Share


  618. Correction to: Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e652.
    >> Share

  619. THYGESEN K, Alpert JS, Jaffe AS, Chaitman BR, et al
    Fourth Universal Definition of Myocardial Infarction (2018).
    Circulation. 2018;138:e618-e651.
    >> Share

  620. KATZ S, Smilowitz NR, Hochman JS
    Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic Shock.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038279.
    >> Share

  621. KHERA AV, Chaffin M, Zekavat SM, Collins RL, et al
    Whole Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized with Early-Onset Myocardial Infarction.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.035658.
    >> Share

  622. KAPUR NK, Alkhouli M, DeMartini T, Faraz H, et al
    Unloading the Left Ventricle Before Reperfusion in Patients with Anterior ST-Segment Elevation Myocardial Infarction: A Pilot Study Using the Impella CP((R)).
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038269.
    >> Share

  623. ARORA S, Stouffer GAR, Kucharska-Newton A, Qamar A, et al
    Twenty Year Trends and Sex Differences in Young Adults Hospitalized with Acute Myocardial Infarction: The ARIC Community Surveillance Study.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.037137.
    >> Share

  624. THIELE H, Zeymer U, Thelemann N, Neumann FJ, et al
    Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038201.
    >> Share

  625. BANGALORE S
    The Elusive Late Benefit of Biodegradable Polymer Drug Eluting Stents.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038378.
    >> Share

  626. KUFNER S, Joner M, Thannheimer A, Hoppmann P, et al
    Ten-Year Clinical Outcomes From a Trial of Three Limus-Eluting Stents With Different Polymer Coatings in Patients With Coronary Artery Disease: Results From the ISAR-TEST 4 Randomized Trial.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038065.
    >> Share

  627. MCGUIRE DK, Alexander JH, Johansen OE, Perkovic V, et al
    Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038352.
    >> Share

  628. LLOYD-JONES DM, Braun LT, Ndumele CE, Smith SC Jr, et al
    Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease.
    Circulation. 2018 Nov 10:CIR0000000000000638. doi: 10.1161/CIR.0000000000000638.
    >> Share

  629. ALASHI A, Lang R, Seballos R, Feinleib S, et al
    Dilation of the Proximal Thoracic Aorta in an Asymptomatic Primary Prevention Population Undergoing Noncontrast Chest Computed Tomography.
    Circulation. 2018 Nov 10. doi: 10.1161/CIRCULATIONAHA.118.036191.
    >> Share

  630. VON BORNSTADT D, Wang H, Paulsen MJ, Goldstone AB, et al
    Rapid Self-Assembly of Bioengineered Cardiovascular Bypass Grafts From Scaffold-Stabilized, Tubular Bilevel Cell Sheets.
    Circulation. 2018;138:2130-2144.
    >> Share

  631. ROCHA RV, Tam DY, Karkhanis R, Nedadur R, et al
    Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.
    Circulation. 2018;138:2081-2090.
    >> Share

  632. DOMANSKI MJ, Farkouh ME
    Optimal Treatment of Patients With Left Ventricular Dysfunction and Severe Coronary Artery Disease.
    Circulation. 2018;138:2079-2080.
    >> Share

  633. RUEL M, Gardner TJ
    Introduction to the 2018 Cardiovascular Surgery-Themed Issue.
    Circulation. 2018;138:2075.
    >> Share

  634. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay.
    Circulation. 2018 Nov 6:CIR0000000000000628. doi: 10.1161/CIR.0000000000000628.
    >> Share

    October 2018
  635. VIGEN R, Kutscher P, Fernandez F, Yu A, et al
    Evaluation of a Novel Rule-Out Myocardial Infarction Protocol Incorporating High-Sensitivity Troponin T in a US Hospital.
    Circulation. 2018;138:2061-2063.
    >> Share

  636. VAN LEEUWEN MAH, van der Hoeven NW, Janssens GN, Everaars H, et al
    Evaluation of Microvascular Injury in Revascularized Patients with ST Elevation Myocardial Infarction Treated with Ticagrelor versus Prasugrel: The REDUCE-MVI Trial.
    Circulation. 2018 Oct 30. doi: 10.1161/CIRCULATIONAHA.118.035931.
    >> Share

  637. MATSUMOTO J, Takada S, Kinugawa S, Furihata T, et al
    Brain-Derived Neurotrophic Factor Improves Limited Exercise Capacity in Mice With Heart Failure.
    Circulation. 2018;138:2064-2066.
    >> Share

  638. MAULER M, Herr N, Schoenichen C, Witsch T, et al
    Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
    Circulation. 2018 Oct 25. doi: 10.1161/CIRCULATIONAHA.118.033942.
    >> Share

  639. INZUCCHI SE, Kosiborod M, Fitchett D, Wanner C, et al
    Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.
    Circulation. 2018;138:1904-1907.
    >> Share

  640. DONZELLI A, Schivalocchi A, Giudicatti G
    Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Effica
    Circulation. 2018;138:1912-1913.
    >> Share

  641. KOH KK
    Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy Internat
    Circulation. 2018;138:1914-1915.
    >> Share

  642. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    >> Share

  643. NISHI T, Piroth Z, De Bruyne B, Jagic N, et al
    Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
    Circulation. 2018;138:1797-1804.
    >> Share

  644. NICCOLI G, Montone RA, Sabato V, Crea F, et al
    Role of Allergic Inflammatory Cells in Coronary Artery Disease.
    Circulation. 2018;138:1736-1748.
    >> Share

  645. CHAPMAN AR, Hesse K, Andrews J, Ken Lee K, et al
    High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome.
    Circulation. 2018;138:1654-1665.
    >> Share

  646. VAKAMUDI S, Jellis C, Mick S, Wu Y, et al
    Sex Differences in the Etiology of Surgical Mitral Valve Disease.
    Circulation. 2018;138:1749-1751.
    >> Share

  647. JAMES M, Manns B
    Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease.
    Circulation. 2018;138:1515-1518.
    >> Share

  648. VERMA S, Leiter LA, Mazer CD, Bain SC, et al
    Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Circulation. 2018;138:1605-1607.
    >> Share

  649. CLAGGETT B, Lachin JM, Hantel S, Fitchett D, et al
    Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
    Circulation. 2018;138:1599-1601.
    >> Share

  650. BONELLO L, Angiolillo DJ, Aradi D, Sibbing D, et al
    P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.
    Circulation. 2018;138:1582-1596.
    >> Share

  651. DAI Y, Song J, Li W, Yang T, et al
    RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
    Circulation. 2018 Oct 5. doi: 10.1161/CIRCULATIONAHA.118.033700.
    >> Share

  652. LINDOW T, Warren S, Pahlm O
    Two Patients With Inferior ST-Segment-Elevation Myocardial Infarction.
    Circulation. 2018;138:1481-1484.
    >> Share

  653. KASKI JC, Crea F, Gersh BJ, Camici PG, et al
    Reappraisal of Ischemic Heart Disease.
    Circulation. 2018;138:1463-1480.
    >> Share

  654. NEELAND IJ, Poirier P, Despres JP
    Response by Neeland et al to Letter Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1496-1497.
    >> Share

  655. KAHN HS
    Letter by Kahn Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1494-1495.
    >> Share

    September 2018
  656. FAN Q, Tao R, Zhang H, Xie H, et al
    Dectin-1 Contributes to Myocardial Ischemia-Reperfusion Injury by Regulating Macrophage Polarization and Neutrophil Infiltration.
    Circulation. 2018 Sep 27. doi: 10.1161/CIRCULATIONAHA.118.036044.
    >> Share

  657. ROLLINI F, Franchi F
    Standard- and Low-Dose Ticagrelor After Percutaneous Coronary Intervention.
    Circulation. 2018;138:1301-1303.
    >> Share

  658. GIMPEL D, Ray M
    Time to Get a @Handle on Twitter and Cardiovascular Medicine.
    Circulation. 2018;138:1285-1286.
    >> Share

  659. KUEHN BM
    Boosting Women's Participation in Cardiovascular Trials.
    Circulation. 2018;138:1366-1367.
    >> Share

  660. LEMESLE G
    Aspirin on Top of Anticoagulation in Patients with Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037440.
    >> Share

  661. MATSUMURA-NAKANO Y, Shizuta S, Komasa A, Morimoto T, et al
    An Open-Label Randomized Trial Comparing Oral Anticoagulation with and without Single Antiplatelet Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease Beyond One Year after Coronary Stent Implantation: The OAC-ALONE Study.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.036768.
    >> Share

  662. FEARON WF, Achenbach S, Engstrom T, Assali A, et al
    Accuracy of Fractional Flow Reserve Derived From Coronary Angiography.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037350.
    >> Share

  663. PAPAFAKLIS MI, Baumbach A
    From Lumenogram to "Functional Angiography" and the Evolution of Virtual FFR: Has the Time Come for Outcome-Based Trials?
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037528.
    >> Share

  664. RODEN DM
    Growing Pains in Cardiovascular Genetics.
    Circulation. 2018;138:1206-1209.
    >> Share

  665. FANAROFF AC, Zakroysky P, Wojdyla D, Kaltenbach LA, et al
    Relationship Between Operator Volume and Long-Term Outcomes after Percutaneous Coronary Intervention: A Report from the NCDR CathPCI Registry.
    Circulation. 2018 Sep 12. doi: 10.1161/CIRCULATIONAHA.117.033325.
    >> Share

  666. CHAPMAN AR, Mills NL
    Response To Letter Regarding Article "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1178.
    >> Share

  667. MADIAS JE
    Letter by Madias Regarding Article, "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1176-1177.
    >> Share

  668. WHITE WB
    Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes.
    Circulation. 2018;138:1127-1129.
    >> Share

  669. HSUE PY, Waters DD
    Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor.
    Circulation. 2018;138:1113-1115.
    >> Share

  670. WENGER NK, Lorell BH, Bairey Merz CN
    Recent Legislation, Public Policy Changes, and Women's Cardiovascular Health.
    Circulation. 2018;138:1082-1084.
    >> Share

  671. YASUDA S, Miyamoto Y, Ogawa H
    Current Status of Cardiovascular Medicine in the Aging Society of Japan.
    Circulation. 2018;138:965-967.
    >> Share

    August 2018
  672. SHARKEY SW, Maron BJ, Kloner RA
    The Case for Takotsubo Cardiomyopathy (Syndrome) as a Variant of Acute Myocardial Infarction.
    Circulation. 2018;138:855-857.
    >> Share

  673. BODEN WE, Bhatt DL
    Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?
    Circulation. 2018;138:858-860.
    >> Share

  674. YI-TONG W
    Letter by Wang Yi-tong Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:852.
    >> Share

  675. ZAUNER CA, Holshouser JW, Littmann L
    Response to Letter Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:853-854.
    >> Share

  676. TAMPAKIS A, Tampaki EC, Gurke L
    Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:848-849.
    >> Share

  677. WANNER C, von Eynatten M, Zinman B
    Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:850-851.
    >> Share

  678. KOH KK
    Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
    Circulation. 2018;138:846-847.
    >> Share

  679. KYRLE PA, Eichinger S
    D-Dimer for Long-Term Risk Prediction in Patients After Acute Coronary Syndrome.
    Circulation. 2018;138:724-726.
    >> Share

  680. HANDY CE, Quispe R, Pinto X, Blaha MJ, et al
    Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment.
    Circulation. 2018;138:727-734.
    >> Share

  681. MATTHEWS DR, Perkovic V, Mahaffey KW
    Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist".
    Circulation. 2018;138:660-661.
    >> Share

  682. HNID K
    Letter by Hnid Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:653-654.
    >> Share

  683. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:649-650.
    >> Share

  684. KOH KK
    Letter by Koh Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:651-652.
    >> Share

  685. DINU M, Pagliai G, Sofi F
    Response by Dinu et al to Letters Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
    Circulation. 2018;138:655.
    >> Share

  686. LOWENSTEIN CJ, Weisfeldt ML, Mitchell JH
    Sarnoff Cardiovascular Research Foundation.
    Circulation. 2018;138:554-556.
    >> Share

    July 2018
  687. VACCARINO V, Bremner JD, Raggi P
    Response by Vaccarino et al to Letter Regarding Article, "Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms".
    Circulation. 2018;138:548-549.
    >> Share


  688. Correction to: European Society of Cardiology-Recommended Coronary Artery Disease Consortium Pretest Probability Scores More Accurately Predict Obstructive Coronary Disease and Cardiovascular Events Than the Diamond and Forrester Score: The Partners R
    Circulation. 2018;138:e80.
    >> Share

  689. JIANG X, Tian H, Qiao S
    Letter by Jiang et al Regarding Article, "Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction".
    Circulation. 2018;138:543.
    >> Share

  690. KAIER TE, Twerenbold R, Puelacher C, Marjot J, et al
    Response by Kaier et al to Letter Regarding Article, "Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction".
    Circulation. 2018;138:544-545.
    >> Share

  691. SINGH AD, Mian A
    Letter by Singh and Mian Regarding Article, "Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction: Sex Differences and Mechanisms".
    Circulation. 2018;138:546-547.
    >> Share

  692. OMLAND T
    Can Circulating B-Type Natriuretic Peptide Concentrations Guide Treatment of Obstructive Left Main Coronary Artery Disease?
    Circulation. 2018;138:479-482.
    >> Share


  693. Correction to: ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018;138:e77.
    >> Share


  694. Correction to: Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018;138:e76.
    >> Share

  695. ANGIOLILLO DJ, Goodman SG, Bhatt DL, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.
    Circulation. 2018;138:527-536.
    >> Share

  696. SHEN C, Ge J
    Epidemic of Cardiovascular Disease in China.
    Circulation. 2018;138:342-344.
    >> Share

  697. FUERNAU G, Beck J, Desch S, Eitel I, et al
    Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial.
    Circulation. 2018 Jul 19. pii: CIRCULATIONAHA.117.032722.
    >> Share

  698. MCCORD J, Newby LK, deFilippi CR
    Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.
    Circulation. 2018;138:316-318.
    >> Share

  699. GOLDBERG IJ, Reue K, Abumrad NA, Bickel PE, et al
    Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop.
    Circulation. 2018;138:305-315.
    >> Share

  700. SHEN YM, Nagalla S
    Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.
    Circulation. 2018;138:229-231.
    >> Share

  701. BONACA MP, Sabatine MS
    Response by Bonaca and Sabatine to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Resea
    Circulation. 2018;138:222-223.
    >> Share

  702. ALKHALIL M
    Letter by Alkhalil Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibitio
    Circulation. 2018;138:220-221.
    >> Share

  703. CALABRO P, Gragnano F, Cesaro A
    Letter by Calabro et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhi
    Circulation. 2018;138:218-219.
    >> Share

  704. IBRAHIM K, Shah R, McEvoy JW
    Response by Ibrahim et al to Letter Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggreg
    Circulation. 2018;138:216-217.
    >> Share

  705. KIKKERT WJ, Delewi R, Claessen BEPM
    Letter by Kikkert et al Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With T
    Circulation. 2018;138:214-215.
    >> Share

  706. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    >> Share

  707. KOENIG W
    Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?
    Circulation. 2018;138:150-153.
    >> Share

  708. BASCOM KE, Seder DB
    Response by Bascom and Seder to Letter Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:120-121.
    >> Share

  709. VOICU S, Megarbane B, Sideris G
    Letter by Voicu et al Regarding Article, "Derivation and Validation of the CREST Model for Very Early Prediction of Circulatory Etiology Death in Patients Without ST-Segment-Elevation Myocardial Infarction After Cardiac Arrest".
    Circulation. 2018;138:118-119.
    >> Share

  710. ZARZOUR A, Kim HW, Weintraub NL
    Understanding Obesity-Related Cardiovascular Disease: It's All About Balance.
    Circulation. 2018;138:64-66.
    >> Share

  711. NASSIF ME, Kosiborod M
    Are We Ready to Bell The Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes.
    Circulation. 2018;138:4-6.
    >> Share

  712. SHIRAKAWA K, Endo J, Kataoka M, Katsumata Y, et al
    IL-10-STAT3-Galectin-3 Axis is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.118.035047.
    >> Share

  713. SHAH ASV, Stelzle D, Lee KK, Beck EJ, et al
    Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
    Circulation. 2018 Jul 2. pii: CIRCULATIONAHA.117.033369.
    >> Share

    June 2018
  714. LABARTHE DR, Lloyd-Jones DM
    50x50x50: Cardiovascular Health and the Cardiovascular Disease Endgame.
    Circulation. 2018 Jun 27. pii: CIRCULATIONAHA.118.035985.
    >> Share

  715. BANGALORE S, Toklu B, Patel N, Feit F, et al
    Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Circulation. 2018 Jun 26. pii: CIRCULATIONAHA.118.034456.
    >> Share

  716. NEUEN BL, Ohkuma T, Neal B, Matthews DR, et al
    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data from the CANVAS Program.
    Circulation. 2018 Jun 25. pii: CIRCULATIONAHA.118.035901.
    >> Share

  717. RICCIOTTI E, Castro C, Tang SY, Briggs WTE, et al
    Cyclooxygenase-2, Asymmetric Dimethylarginine and the Cardiovascular Hazard from NSAIDs.
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.033540.
    >> Share

  718. ORME RC, Parker WAE, Thomas MR, Judge HM, et al
    Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).
    Circulation. 2018 Jun 21. pii: CIRCULATIONAHA.118.034790.
    >> Share

  719. THIENE G, Saffitz JE
    Autopsy as a Source of Discovery in Cardiovascular Medicine: Then and Now.
    Circulation. 2018;137:2683-2685.
    >> Share

  720. ZHANG M, Solomon DH, Desai RJ, Kang EH, et al
    Assessment of Cardiovascular Risk in Older Patients with Gout Initiating Febuxostat versus Allopurinol: A Population-Based Cohort Study.
    Circulation. 2018 Jun 13. pii: CIRCULATIONAHA.118.033992.
    >> Share

  721. BOHULA EA, Wiviott SD, Giugliano RP, Park JG, et al
    Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
    Circulation. 2018;137:2662-2663.
    >> Share

  722. KOH KK
    Letter by Koh Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2660-2661.
    >> Share

  723. CORDERO A, Bertomeu-Gonzalez V, Rodriguez-Manero M
    Letter by Cordero et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2658-2659.
    >> Share

  724. THOMOPOULOS C, Michalopoulou H
    Letter by Thomopoulos and Michalopoulou Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Tr
    Circulation. 2018;137:2656-2657.
    >> Share

  725. DEL PINTO R, Ferri C, Borghi C
    Letter by Del Pinto et al Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
    Circulation. 2018;137:2654-2655.
    >> Share

  726. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    >> Share

  727. ROBERTS R
    Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease.
    Circulation. 2018;137:2554-2556.
    >> Share

  728. UDDIN SMI, Mirbolouk M, Dardari Z, Feldman DI, et al
    Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis.
    Circulation. 2018 Jun 11. pii: CIRCULATIONAHA.118.033990.
    >> Share

  729. BADERTSCHER P, Boeddinghaus J, Twerenbold R, Nestelberger T, et al
    Direct Comparison of the 0/1h and 0/3h Algorithms for Early Rule-Out of Acute Myocardial Infarction.
    Circulation. 2018;137:2536-2538.
    >> Share

  730. PFEFFER MA, Rutherford JD
    Therapeutic Attenuation of Cardiac Remodeling After Acute Myocardial Infarction: A Conversation With Marc A. Pfeffer, MD, PhD.
    Circulation. 2018;137:2430-2434.
    >> Share

  731. HYMAN MC, Patel PA, Giri J
    Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
    Circulation. 2018;137:2545-2546.
    >> Share

  732. SNIECINSKI RM, Mackensen GB, Kertai MD
    Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
    Circulation. 2018;137:2543-2544.
    >> Share

  733. MAGNANI JW, Mujahid MS, Aronow HD, Cene CW, et al
    Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Jun 4. pii: CIR.0000000000000579.
    >> Share

    May 2018
  734. DEVEREAUX PJ
    Suboptimal Outcome of Myocardial Infarction After Noncardiac Surgery: Physicians Can and Should Do More.
    Circulation. 2018;137:2340-2343.
    >> Share


  735. Correction to: Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.
    Circulation. 2018;137:e820.
    >> Share

  736. VALLEJO-VAZ AJ, Packard CJ, Ray KK
    Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL
    Circulation. 2018;137:2419-2420.
    >> Share

  737. KOH KK
    Letter by Koh Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From th
    Circulation. 2018;137:2417-2418.
    >> Share

  738. LOWE AL, Collet TH, Rodondi N
    Letter by Lowe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses
    Circulation. 2018;137:2415-2416.
    >> Share

  739. RIJNBERG FM, Hazekamp MG, Wentzel JJ, de Koning PJH, et al
    Energetics of Blood Flow in Cardiovascular Disease: Concept and Clinical Implications of Adverse Energetics in Patients With a Fontan Circulation.
    Circulation. 2018;137:2393-2407.
    >> Share

  740. VOLGMAN AS, Palaniappan LS, Aggarwal NT, Gupta M, et al
    Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.
    Circulation. 2018 May 24. pii: CIR.0000000000000580.
    >> Share

  741. KIRTANE AJ
    ORBITA2: Bringing Some Oxygen Back to PCI in Stable Ischemic Heart Disease?
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.035331.
    >> Share

  742. PUYMIRAT E, Simon T, Danchin N
    Response by Puymirat et al to Letter Regarding Article, "Acute Myocardial Infarction Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST Elevation or Non-ST
    Circulation. 2018;137:2307-2308.
    >> Share

  743. RODRIGUEZ-GRANILLO GA, Rodriguez AE, Milei J
    Letter by Rodriguez-Granillo et al Regarding Article, "Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-
    Circulation. 2018;137:2305-2306.
    >> Share

  744. AL-LAMEE R, Howard JP, Shun-Shin MJ, Thompson D, et al
    Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease: Physiology-Stratified Analysis of ORBITA.
    Circulation. 2018 May 22. pii: CIRCULATIONAHA.118.033801.
    >> Share

  745. OLDGREN J, Sundstrom J
    Response by Oldgren and Sundstrom to Letter Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2313.
    >> Share

  746. YI-TONG W
    Letter by Yi-tong Regarding Article, "Low-Dose Aspirin Discontinuation and Risk of Cardiovascular Events: A Swedish Nationwide, Population-Based Cohort Study".
    Circulation. 2018;137:2312.
    >> Share

  747. MENDY A
    Association of Urinary Nitrate With Lower Prevalence of Hypertension and Stroke and With Reduced Risk of Cardiovascular Mortality.
    Circulation. 2018;137:2295-2297.
    >> Share

  748. KENGNE AP, Ntsekhe M
    Challenges of Cardiovascular Disease Risk Evaluation in People Living With HIV Infection.
    Circulation. 2018;137:2215-2217.
    >> Share

  749. LINGVAY I, Leiter LA
    Use of GLP-1 RAs in Cardiovascular Disease Prevention: A Practical Guide.
    Circulation. 2018;137:2200-2202.
    >> Share

  750. RIMM EB, Appel LJ, Chiuve SE, Djousse L, et al
    Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2018 May 17. pii: CIR.0000000000000574.
    >> Share

  751. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
    Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2186-2187.
    >> Share

  752. ROMEO JLR, Bogers AJJC, Mokhles MM
    Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2184-2185.
    >> Share

  753. VERMA S, Bhatt DL, Bain SC, Buse JB, et al
    Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial.
    Circulation. 2018;137:2179-2183.
    >> Share

  754. SCHULTZ WM, Kelli HM, Lisko JC, Varghese T, et al
    Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions.
    Circulation. 2018;137:2166-2178.
    >> Share

  755. BROWN HL, Warner JJ, Gianos E, Gulati M, et al
    Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gyneco
    Circulation. 2018 May 10. pii: CIR.0000000000000582.
    >> Share

  756. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    >> Share

  757. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    >> Share

  758. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    >> Share

  759. BARTER PJ
    High- Versus Low-Dose Statin: Effects on Cardiovascular Events and All-Cause Death.
    Circulation. 2018;137:2013-2015.
    >> Share

  760. TAGUCHI I, Iimuro S, Iwata H, Takashima H, et al
    High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Circulation. 2018;137:1997-2009.
    >> Share

  761. MAYNE SL, Widome R, Carroll AJ, Schreiner PJ, et al
    Longitudinal Associations of Smoke-Free Policies and Incident Cardiovascular Disease: CARDIA Study.
    Circulation. 2018 May 7. pii: CIRCULATIONAHA.117.032302.
    >> Share

  762. KARAM N, Pechmajou L, Dumas F, Bougouin W, et al
    Comprehensive Assessment of Coronary Artery Disease in Sports-Related Sudden Cardiac Arrest.
    Circulation. 2018 May 2. pii: CIRCULATIONAHA.118.034664.
    >> Share

  763. GOLDWASSER D, Elizari M, Bayes de Luna A
    Response by Goldwasser et al to Letter Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1977-1978.
    >> Share

  764. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Chronic Myocardial Infarction: Where Is It Located?"
    Circulation. 2018;137:1976.
    >> Share

  765. BULLUCK H, Dharmakumar R, Arai AE, Berry C, et al
    Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions.
    Circulation. 2018;137:1949-1964.
    >> Share

  766. THOMPSON PD
    Fitness, Exercise, and Coronary Calcification.
    Circulation. 2018;137:1896-1898.
    >> Share

    April 2018
  767. WEI WQ, Li X, Feng Q, Kubo M, et al
    LPA Variants are Associated with Residual Cardiovascular Risk in Patients Receiving Statins.
    Circulation. 2018 Apr 27. pii: CIRCULATIONAHA.117.031356.
    >> Share

  768. KLEINMAN ME, Perkins GD, Bhanji F, Billi JE, et al
    ILCOR Scientific Knowledge Gaps and Clinical Research Priorities for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: A Consensus Statement.
    Circulation. 2018 Apr 26. pii: CIR.0000000000000561.
    >> Share

  769. VAN DER LINDEN N, Wildi K, Twerenbold R, Pickering JW, et al
    Combining High Sensitivity Cardiac Troponin I and Cardiac Troponin T in the Early Diagnosis of Acute Myocardial Infarction.
    Circulation. 2018 Apr 24. pii: CIRCULATIONAHA.117.032003.
    >> Share

  770. RUBINI GIMENEZ M, Badertscher P, Twerenbold R, Boeddinghaus J, et al
    Impact of the US Food and Drug Administration-Approved Sex-Specific Cutoff Values for High-Sensitivity Cardiac Troponin T to Diagnose Myocardial Infarction.
    Circulation. 2018;137:1867-1869.
    >> Share

  771. HASEEB S, Alexander B, Baranchuk A
    Response by Haseeb et al to Letter Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1880-1881.
    >> Share

  772. THORNTON SN
    Letter by Thornton Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review".
    Circulation. 2018;137:1879.
    >> Share

  773. HUANG ZP, Wang DZ
    miR-22 in Smooth Muscle Cells: A Potential Therapy for Cardiovascular Disease.
    Circulation. 2018;137:1842-1845.
    >> Share

  774. FERNANDEZ-JIMENEZ R, Martin-Garcia A, Barreiro-Perez M, Sanchez-Gonzalez J, et al
    Response by Fernandez-Jimenez et al to Letters Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1754-1755.
    >> Share

  775. STIERMAIER T, Bogaert J, Eitel I
    Letter by Stiermaier et al Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1752-1753.
    >> Share

  776. SACHA J, Feusette P
    Letter by Sacha and Feusette Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1750-1751.
    >> Share

  777. BULLUCK H, Hausenloy DJ
    Letter by Bulluck and Hausenloy Regarding Article, "Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing Myocardial Area at Risk and Salvage".
    Circulation. 2018;137:1748-1749.
    >> Share

  778. VERHEUGT FWA
    Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
    Circulation. 2018;137:1655-1657.
    >> Share

  779. REDFORS B, Chen S, Crowley A, Ben-Yehuda O, et al
    B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis from the EXCEL Trial.
    Circulation. 2018 Apr 17. pii: CIRCULATIONAHA.118.033631.
    >> Share

  780. AHMAD FS, Chan C, Rosenman MB, Post WS, et al
    Response by Ahmad et al to Letter Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1761-1762.
    >> Share

  781. MEWTON N, Bergerot C, Cornu C
    Letter by Mewton et al Regarding Article, "Validity of Cardiovascular Data From Electronic Sources: The Multi-Ethnic Study of Atherosclerosis and HealthLNK".
    Circulation. 2018;137:1759-1760.
    >> Share

  782. PACK QR, Priya A, Lagu TC, Pekow PS, et al
    Inpatient Echocardiography Use for Common Cardiovascular Conditions.
    Circulation. 2018;137:1745-1747.
    >> Share

  783. BAIBHAV B, Gedela M, Moulton M, Pavlides G, et al
    Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.
    Circulation. 2018;137:1731-1739.
    >> Share

  784. BAKAEEN FG, Svensson LG
    Why Don't We Kill 2 Birds with 1 Stone? Less Adverse Cardiac Events and Improved Survival With Multiarterial Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1708-1711.
    >> Share

  785. GAUDINO M, Fremes SE, Taggart DP
    Continuing Conundrum of Multiple Arterial Conduits for Coronary Artery Bypass Grafting.
    Circulation. 2018;137:1658-1660.
    >> Share

  786. PATEL KV, Pandey A, de Lemos JA
    A Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine.
    Circulation. 2018 Apr 11. pii: CIRCULATIONAHA.118.035289.
    >> Share

  787. FIOL-SALA M, Bayes de Luna A
    Response by Fiol-Sala and Bayes de Luna to Letter Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1653.
    >> Share

  788. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Acute Coronary Syndrome: What Is the Affected Artery? Where Is the Occlusion Located? And How Important Is the Myocardial Mass Involved?"
    Circulation. 2018;137:1652.
    >> Share

  789. NALLAMOTHU BK, Hill JA
    Response by Nallamothu and Hill to Letter Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1643-1644.
    >> Share

  790. KATRITSIS DG
    Letter by Katritsis Regarding Article, "Preprints and Cardiovascular Science: Prescient or Premature?"
    Circulation. 2018;137:1641-1642.
    >> Share

  791. SHARIFZADEHGAN A, Marijon E, Bougouin W, Karam N, et al
    Sudden Cardiovascular Arrest During Sexual Intercourse.
    Circulation. 2018;137:1638-1640.
    >> Share

  792. DUNBAR SB, Khavjou OA, Bakas T, Hunt G, et al
    Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.
    Circulation. 2018 Apr 9. pii: CIR.0000000000000570.
    >> Share

  793. TIKKANEN E, Gustafsson S, Ingelsson E
    Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
    Circulation. 2018 Apr 9. pii: CIRCULATIONAHA.117.032432.
    >> Share

  794. SABATINE MS, De Ferrari GM, Giugliano RP, Huber K, et al
    Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER.
    Circulation. 2018 Apr 6. pii: CIRCULATIONAHA.118.034309.
    >> Share

  795. VALLEJO-VAZ AJ, Fayyad R, Boekholdt SM, Hovingh GK, et al
    Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial.
    Circulation. 2018 Apr 4. pii: CIRCULATIONAHA.117.032318.
    >> Share

  796. OLDE ENGBERINK RHG, van den Born BH, Peters-Sengers H, Vogt L, et al
    Response by Olde Engberink et al to Letter Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
    Circulation. 2018;137:1538-1539.
    >> Share

  797. GRAUDAL N, Mente A
    Letter by Graudal and Mente Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk".
    Circulation. 2018;137:1536-1537.
    >> Share

  798. AUGER N, Potter BJ, Bilodeau-Bertrand M, Paradis G, et al
    Long-Term Risk of Cardiovascular Disease in Women Who Have Had Infants With Heart Defects.
    Circulation. 2018 Apr 2. pii: CIRCULATIONAHA.117.030277.
    >> Share

    March 2018
  799. PASUPATHY S, Tavella R, Beltrame JF
    Response by Pasupathy et al to Letters Regarding Article, "Early Use of N-acetylcysteine (NAC) With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Reduces Myocardial Inf
    Circulat